View Filing Data

3,195

5,478

Long-term marketable investments

5,118

3,595

Other current assets

235

164

Total current assets

16,503

16,039

^[1]

1,164

473

Property, plant, and equipment

28,240

23,672

Intangible assets

340

331

Deferred tax assets

837

1,022

Goodwill

1,228

Other noncurrent assets

575

611

Total assets

48,887

43,376

Liabilities and equity

Accounts payable and accrued expenses

4,626

4,374

Other current liabilities

1,310

859

454

521

Total current liabilities

6,390

5,754

Long-term debt

4,541

3,777

Noncurrent unearned government incentives

636

227

Other noncurrent liabilities

452

354

Total liabilities

12,019

10,112

Commitments and contingencies

Redeemable convertible notes

Redeemable noncontrolling interest

Micron shareholders' equity

Common stock, $0.10 par value, 3,000 shares authorized, 1,182 shares issued and 1,106 outstanding (1,170 shares issued and 1,161 outstanding as of August 30, 2018)

118

117

Additional capital

8,214

8,201

Retained earnings

30,761

24,395

Treasury stock, 76 shares held (9 shares as of August 30, 2018)

(3,221)

(429)

Accumulated other comprehensive income

Total Micron shareholders' equity

35,881

32,294

Noncontrolling interests in subsidiaries

889

870

Total equity

36,770

33,164

Total liabilities and equity

$ 48,887

$ 43,376

[1]	The maturities of long-term marketable securities range from one to four years.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Aug. 29, 2019	Aug. 30, 2018
Liabilities and equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,182	1,170
Common Stock, outstanding (in shares)	1,106	1,161
Treasury Stock, held (in shares)	76	9

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Total Micron Shareholders' Equity	Noncontrolling Interests in Subsidiaries
Balance (in shares) at Sep. 01, 2016		1,094
Balance at Sep. 01, 2016	$ 12,928	$ 109	$ 7,736	$ 5,299	$ (1,029)	$ (35)	$ 12,080	$ 848
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,090			5,089			5,089	1
Other comprehensive income (loss), net	64					64	64
Stock issued under stock plans (in shares)		20
Stock issued under stock plans	142	$ 3	139				142
Stock-based compensation expense	215		217	(2)			215
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock	(35)	$ 0	(13)	(22)			(35)
Stock issued to Nanya for Inotera Acquisition (in shares)		4
Stock issued to Nanya for Inotera Acquisition	995	$ 0	70				995
Treasury stock issued to Nanya for Inotera Acquisition				(104)	1,029
Settlement of capped calls	125		192		(67)		125
Reclassification of redeemable convertible notes, net	(21)		(21)				(21)
Conversion and repurchase of convertible notes	(33)		(33)				(33)
Balance (in shares) at Aug. 31, 2017		1,116
Balance at Aug. 31, 2017	19,470	$ 112	8,287	10,260	(67)	29	18,621	849
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,138			14,135			14,135	3
Other comprehensive income (loss), net	$ (19)					(19)	(19)
Stock issued in public offering (in shares)	34	34
Stock issued in public offering	$ 1,366	$ 3	1,363				1,366
Stock issued under stock plans (in shares)		22
Stock issued under stock plans	289	$ 2	287				289
Stock-based compensation expense	198		198				198
Contributions from noncontrolling interests	18						0	18
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock	(71)	$ 0	(71)				(71)
Settlement of capped calls	0		429		(429)		0
Reclassification of redeemable convertible notes, net	18		18				18
Conversion and repurchase of convertible notes	$ (2,243)		(2,310)				(2,243)
Decrease in treasury stock due to reissuance of treasury shares					67
Balance (in shares) at Aug. 30, 2018	1,170	1,170
Balance at Aug. 30, 2018	$ 33,164	$ 117	8,201	24,395	(429)	10	32,294	870
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,358
Net income (loss), excluding redeemable noncontrolling interest	6,349			6,313			6,313	36
Other comprehensive income (loss), net	(1)					(1)	(1)
Stock issued under stock plans (in shares)		14
Stock issued under stock plans	179	$ 1	178				179
Stock-based compensation expense	243		243				243
Repurchase and retirement of stock (in shares)		(2)
Repurchase and retirement of stock		$ 0		(39)
Repurchase of stock, accelerated share repurchase program adj			103
Repurchase of treasury stock					(2,792)
Repurchase of treasury stock (held and retired)	(2,728)						(2,728)
Acquisitions of noncontrolling interests	(16)		1				1	(17)
Reclassification of redeemable convertible notes, net	3		3				3
Conversion and repurchase of convertible notes	$ (515)		(515)				(515)
Balance (in shares) at Aug. 29, 2019	1,182	1,182
Balance at Aug. 29, 2019	$ 36,770	$ 118	$ 8,214	$ 30,761	$ (3,221)	$ 9	$ 35,881	$ 889

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Cash flows from operating activities
Net income	$ 6,358	$ 14,138	$ 5,090
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	5,424	4,759	3,861
Amortization of debt discount and other costs	49	101	125
Loss on debt prepayments, repurchases, and conversions	396	385	99
Stock-based compensation	243	198	215
Gain on remeasurement of previously-held equity interest in Inotera	0	0	(71)
Change in operating assets and liabilities
Receivables	2,431	(1,734)	(1,651)
Inventories	(1,528)	(472)	50
Accounts payable and accrued expenses	(174)	668	456
Payments attributed to intercompany balances with Inotera	0	0	(361)
Deferred income taxes, net	150	(265)	(22)
Other	(160)	(378)	362
Net cash provided by operating activities	13,189	17,400	8,153
Cash flows from investing activities
Expenditures for property, plant, and equipment	(9,780)	(8,879)	(4,734)
Purchases of available-for-sale securities	(4,218)	(760)	(1,239)
Acquisition of Inotera	0	0	(2,634)
Proceeds from maturities of available-for-sale securities	1,541	320	194
Proceeds from sales of available-for-sale securities	1,504	604	776
Proceeds from government incentives	748	355	21
Other	120	144	79
Net cash provided by (used for) investing activities	(10,085)	(8,216)	(7,537)
Cash flows from financing activities
Repayments of debt	(3,340)	(10,194)	(2,558)
Payments to acquire treasury stock	(2,729)	(71)	(36)
Payments on equipment purchase contracts	(75)	(206)	(519)
Proceeds from issuance of debt	3,550	1,009	3,311
Proceeds from issuance of stock	179	1,655	142
Other	(23)	31	9
Net cash provided by (used for) financing activities	(2,438)	(7,776)	349
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	26	(37)	(12)
Net increase in cash, cash equivalents, and restricted cash	692	1,371	953
Cash, cash equivalents, and restricted cash at beginning of period	6,587	5,216	4,263
Cash, cash equivalents, and restricted cash at end of period	7,279	6,587	5,216
Supplemental disclosures
Income taxes paid, net	(524)	(226)	(99)
Interest paid, net of amounts capitalized	(53)	(312)	(468)
Noncash investing and financing activity
Equipment acquisitions on contracts payable and capital leases	$ 119	$ 84	$ 813

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Aug. 29, 2019
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation: Micron Technology, Inc., including its consolidated subsidiaries, is an industry leader in innovative memory and storage solutions. Through our global brands – Micron, Crucial, and Ballistix – our broad portfolio of high-performance memory and storage technologies, including DRAM, NAND, 3D XPoint memory, and NOR, is transforming how the world uses information to enrich life. Backed by 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, 5G, machine learning, and autonomous vehicles, in key market segments like mobile, data center, client, consumer, industrial, graphics, automotive, and networking. The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. Intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Information prior to 2019 is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. See "Recently Adopted Accounting Standards" note. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019, 2018, and 2017 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated. Derivative and Hedging Instruments: We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting Accounting Standards Update ("ASU") 2017-12, beginning in the second quarter of 2018, such amounts are included in the same line item in which the underlying transactions affect earnings. For derivative forward contracts designated as fair value hedges, hedge effectiveness is determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates are recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and is recognized on a straight-line basis over the life of hedges to other non-operating income (expense). We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis. Financial Instruments: Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries. Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year. Government Incentives: We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity. Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. When net realizable value (which requires projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories) is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of average cost or net realizable value analysis and categorize inventories primarily as memory (including DRAM, NAND, and other memory). We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis. Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. Product Warranty: We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material. Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets. Research and Development: Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other R&D costs for certain technologies may be shared with a development partner. Amounts from cost-sharing arrangements are reflected as a reduction of R&D expense. Revenue Recognition: Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical rates of return. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue. Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options or conversion of share units. Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings. Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Aug. 29, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Unconsolidated VIE PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we do not have governance rights. Therefore, we do not consolidate PTI Xi'an. In connection with our assembly services with PTI, as of August 29, 2019 and August 30, 2018, we had net property, plant, and equipment of $50 million and $63 million, respectively, and capital lease obligations of $47 million and $63 million, respectively. Consolidated VIE IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. In January 2019, we exercised our option to acquire Intel's interest in IMFT. Subsequently, Intel set the closing date to occur on October 31, 2019, at which time IMFT will become a wholly-owned subsidiary. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)

Recently Adopted Accounting Standards

12 Months Ended

Aug. 29, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Recently Adopted Accounting Standards

In October 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-16 – Intra-Entity Transfers Other Than Inventory ("ASU 2016-16"), which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. We adopted this ASU in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below.

In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. We adopted this ASU in the first quarter of 2019 under the modified retrospective method, with prospective adoption for amendments related to equity securities without readily determinable fair values. The adoption of this ASU did not have a material impact on our financial statements.

In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers (as amended, "ASC 606"), which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of ASC 606 is that an entity should recognize revenue when it transfers control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASC 606 also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. We adopted ASC 606 in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below. We applied ASC 606 to contracts with customers that had not yet been completed as of the adoption date.

The following table summarizes the effects of adopting ASU 2016-16 and ASC 606:




	Ending Balance as of August 30, 2018		ASU 2016-16			ASC 606			Opening Balance as of August 31, 2018
Receivables	$	5,478	$	—		$	114		$	5,592
Inventories	3,595		—			(5		)	3,590
Other current assets	164		(14		)	30			180
Deferred tax assets	1,022		56			(92		)	986
Other current liabilities	521		—			(4		)	517
Other noncurrent liabilities	354		—			1			355
Retained earnings	24,395		42			50			24,487

As a result of the adoption of ASC 606, the opening balances as of August 31, 2018 for receivables, other current assets, and other current liabilities increased due to the reclassification of allowances for rebates, pricing adjustments, and returns to conform to the new presentation requirements. In addition, the margin from previously deferred sales to distributors was reclassified from other current liabilities to retained earnings. The tax effects of the adoption of ASC 606 were recorded primarily as a reduction of net deferred tax assets, substantially as a result of recognizing income for accounting purposes earlier under ASC 606 than for tax purposes in various jurisdictions.

The effects of ASC 606 to our consolidated statement of operations and balance sheet were as follows:



	Year ended August 29, 2019
	As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606
Revenue	$	23,406		$	(40	)	$	23,366
Cost of goods sold	12,704			(70		)	12,634
Interest expense	(128		)	5			(123		)
Income tax (provision) benefit	(693		)	(19		)	(712		)
Net income attributable to Micron	6,313			16			6,329



As of August 29, 2019	As Reported		Adjustments			Amounts Without the Effects of Adoption of ASC 606
Receivables	$	3,195	$	(94	)	$	3,101
Other current assets	235		(44		)	191
Deferred tax assets	837		79			916
Accounts payable and accrued expenses	4,626		6			4,632
Other current liabilities	454		(30		)	424
Other noncurrent liabilities	452		(1		)	451
Retained earnings	30,761		(34		)	30,727

Recently Issued Accounting Standards Not Yet Adopted	12 Months Ended
Recently Issued Accounting Standards Not Yet Adopted	Aug. 29, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Standards Not Yet Adopted	Recently Issued Accounting Standards Not Yet Adopted In November 2018, the FASB issued ASU 2018-18 – Collaborative Arrangements, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606, which was August 31, 2018, by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We do not anticipate the adoption of this ASU to have a material impact to our financial statements. In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of-use asset and corresponding liability, measured at the present value of lease payments. We will adopt the provisions of this ASU under a modified retrospective method at the beginning of 2020 and not recast prior periods. The adoption of this ASU will result in an increase to our consolidated balance sheet of approximately $550 million for operating lease liabilities and right-of-use assets.

Acquisition of Inotera

12 Months Ended

Aug. 29, 2019

Inotera

Business Acquisition [Line Items]

Acquisition of Inotera

Through December 6, 2016, we held a 33% ownership interest in Inotera, now known as MTTW, Nanya and certain of its affiliates held a 32% ownership interest, and the remaining ownership interest was publicly held. On December 6, 2016, we acquired the 67% remaining interest in Inotera not owned by us (the "Inotera Acquisition") and began consolidating Inotera's operating results. The cash paid for the Inotera Acquisition was funded, in part, with proceeds from the 2021 MSTW Term Loan and the sale of the Micron Shares (as defined below) to Nanya. Inotera manufactures DRAM products at its 300mm wafer fabrication facility in Taoyuan City, Taiwan. From December 2015 until our acquisition of the remaining interest in Inotera, the price for DRAM products purchased by us was based on a formula that equally shared margin between Inotera and us. Under these agreements, we purchased $504 million of DRAM products in 2017 through the date of our acquisition. SG&A expenses for 2017 and 2016 included transaction costs of $13 million and $3 million, respectively, incurred in connection with the Inotera Acquisition.

In connection with the Inotera Acquisition, we revalued our previously-held 33% equity interest to its fair value. In determining the fair value, we used various valuation techniques, including the share price of Inotera prior to the announcement of the Inotera Acquisition and discounted cash flow projections using inputs including discount rate and terminal growth rate (Level 3). As a result, we recognized a non-operating gain of $71 million in 2017.

In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya (the "Micron Shares") and received cash proceeds of $986 million. Because the sale of the Micron Shares to Nanya was contemporaneous with, and contingent upon, the closing of the Inotera Acquisition, the issuance of the Micron Shares was treated in purchase accounting as a non-cash exchange for a portion of the shares of Inotera held by Nanya. The Micron Shares were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, and were subject to certain restrictions on transfers at the time of sale. To reflect the lack of transferability, the fair value of the Micron Shares (based on the trading price of our common stock on the acquisition date) was reduced by a discount of $81 million, based on the implied volatility derived from traded options on our stock and on the duration of the lack of transferability (Level 2).

The allocation of purchase price to assets acquired and liabilities assumed of Inotera was as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from sale of Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

The Inotera Acquisition enhanced our flexibility to drive new technology, optimized the deployment of capital, and enabled us to adapt our product offerings to changes in market conditions. As a result of these synergies, we allocated goodwill of $829 million, $198 million, and $97 million to CNBU, MBU, and EBU, respectively. Goodwill resulting from the Inotera Acquisition is not deductible for Taiwan corporate income tax purposes; however, it is deductible for Taiwan surtax purposes.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations as if the Inotera Acquisition had occurred on September 4, 2015. The pro forma financial information includes the accounting effects of the business combination, including adjustments for depreciation of property, plant, and equipment, interest expense, elimination of intercompany activities, and revaluation of inventories. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Inotera Acquisition occurred on September 4, 2015.



Year ended	August 31, 2017
Net sales	$	20,317
Net income	5,172
Net income attributable to Micron	5,171
Earnings per share
Basic	4.68
Diluted	4.42

The unaudited pro forma financial information for 2017 includes our results for the year ended August 31, 2017 (which includes the results of Inotera since our acquisition of Inotera on December 6, 2016), the results of Inotera for the three months ended November 30, 2016, and the adjustments described above.

Technology Transfer and License Agreements with Nanya

Effective December 6, 2016, the terms of technology transfer and license agreements provided Nanya with options to require us to transfer to Nanya certain technology for Nanya's use and deliverables related to the next DRAM process node generation after our 20nm process node (the "1X Process Node") and the next DRAM process node generation after the 1X Process Node (the "1Y Process Node"). Nanya's option for the 1X Process Node expired unexercised. If Nanya exercises its right for the 1Y Process Node, Nanya would pay us royalties for a license to the transferred 1Y Process Node technology based on revenues from products utilizing the technology, subject to specified caps, and we would also receive an equity interest in Nanya upon the achievement of certain milestones.

Cash and Investments

12 Months Ended

Aug. 29, 2019

Investments [Abstract]

Cash and Investments

Substantially all of our marketable debt and equity investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2019								2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,388	$	—	$	—	$	2,388	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	3,418		—		—		3,418		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposits	1,292		13		1		1,306		806		11		2		819
Corporate bonds	—		550		689		1,239		3		172		272		447
Government securities	36		149		232		417		5		63		103		171
Asset-backed securities	—		67		242		309		—		34		96		130
Commercial paper	18		24		—		42		26		16		—		42
	7,152		$	803	$	1,164	$	9,119	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	127								81
Cash, cash equivalents, and restricted cash	$	7,279							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2019 or August 30, 2018.


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily relates to the MMJ Creditor Payments and government incentives received prior to being earned. The restrictions lapse on the MMJ Creditor Payments upon approval by the trustees and/or Tokyo District Court and for the government incentives upon achieving certain performance conditions.

Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of August 29, 2019, there were no available-for-sale securities that had been in a loss position for longer than 12 months.

Receivables

12 Months Ended

Aug. 29, 2019

Receivables [Abstract]



As of	2019		2018
Trade receivables	$	2,778	$	5,056
Income and other taxes	242		161
Other	175		261
	$	3,195	$	5,478

Inventories

12 Months Ended

Aug. 29, 2019

Inventory Disclosure [Abstract]

Property, Plant and Equipment [Abstract]



As of	2019		2018
Finished goods	$	757	$	815
Work in process	3,825		2,357
Raw materials and supplies	536		423
	$	5,118	$	3,595

Property, Plant, and Equipment

12 Months Ended

Aug. 29, 2019

Property, Plant, and Equipment



As of	2019			2018
Land	$	352		$	345
Buildings (includes $528 and $483, respectively, under capital leases)	10,931			8,680
Equipment⁽¹⁾ (includes $905 and $1,336, respectively, under capital leases)	44,051			38,249
Construction in progress⁽²⁾	1,700			1,162
Software	790			655
	57,824			49,091
Accumulated depreciation (includes $733 and $868, respectively, under capital leases)	(29,584		)	(25,419		)
	$	28,240		$	23,672


⁽¹⁾	Included costs related to equipment not placed into service of $2.33 billion as of August 29, 2019 and $1.73 billion as of August 30, 2018.


⁽²⁾	Included building-related construction, tool installation, and software costs for assets not placed into service.

Depreciation expense was $5.34 billion, $4.66 billion, and $3.76 billion for 2019, 2018, and 2017, respectively. Interest capitalized as part of the cost of property, plant, and equipment was $103 million, $44 million, and $7 million for 2019, 2018, and 2017, respectively.

Intangible Assets and Goodwill

12 Months Ended

Aug. 29, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill



As of	2019					2018
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	583	$	(243	)	$	567	$	(344	)
Non-amortizing assets
In-process R&D	—		—			108		—
Total intangible assets	$	583	$	(243	)	$	675	$	(344	)

Goodwill	$	1,228				$	1,228

In 2019, 2018, and 2017, we capitalized $91 million, $48 million, and $29 million, respectively, for product and process technology with weighted-average useful lives of 8 years, 10 years, and 11 years, respectively. In 2019, we placed $108 million of in-process R&D in service, which is being amortized on a straight-line basis over six years. Expected amortization expense for our intangible assets is $72 million for 2020, $62 million for 2021, $50 million for 2022, $44 million for 2023, and $40 million for 2024.

Accounts Payable and Accrued Expenses

12 Months Ended

Aug. 29, 2019

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses



As of	2019		2018
Accounts payable	$	1,677	$	1,692
Property, plant, and equipment	1,782		1,238
Salaries, wages, and benefits	695		841
Income and other taxes	309		402
Other	163		201
	$	4,626	$	4,374

Debt

12 Months Ended

Aug. 29, 2019

Debt Disclosure [Abstract]

Debt



As of	2019												2018
							Net Carrying Amount								Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Principal		Current		Long-Term		Total⁽¹⁾		Principal		Current		Long-Term		Total⁽¹⁾
IMFT Member Debt	N/A		N/A		$	693	$	693	$	—	$	693	$	1,009	$	—	$	1,009	$	1,009
Capital lease obligations	N/A		4.30	%	591		223		368		591		846		310		536		846
MMJ Creditor Payments	N/A		9.76	%	206		198		—		198		520		$	309	183		492
2024 Notes	4.64	%	4.76	%	600		—		597		597		—		—		—		—
2025 Notes	5.50	%	5.56	%	519		—		516		516		519		—		515		515
2026 Notes	4.98	%	5.07	%	500		—		497		497		—		—		—		—
2027 Notes	4.19	%	4.27	%	900		—		895		895		—		—		—		—
2029 Notes	5.33	%	5.40	%	700		—		696		696		—		—		—		—
2030 Notes	4.66	%	4.73	%	850		—		845		845		—		—		—		—
2032D Notes⁽²⁾	3.13	%	6.33	%	134		—		127		127		143		—		132		132
2033F Notes⁽²⁾⁽³⁾	2.13	%	4.93	%	62		196		—		196		107		235		—		235
2043G Notes	3.00	%	6.76	%	—		—		—		—		1,019		—		682		682
2022 Term Loan B	4.24	%	4.65	%	—		—		—		—		735		5		720		725
					$	5,755	$	1,310	$	4,541	$	5,851	$	4,898	$	859	$	3,777	$	4,636

⁽¹⁾

Net carrying amount is the principal amount less unamortized debt discount and issuance costs. In addition, the net carrying amount as of August 29, 2019 and August 30, 2018 included $135 million and $132 million, respectively, of derivative debt liabilities recognized as a result of our election to settle entirely in cash converted notes with an aggregate principal amount of $44 million and $35 million, respectively.

⁽²⁾

Since the closing price of our common stock exceeded 130% of the conversion price per share for at least 20 trading days in the 30 trading day period ended on June 30, 2019, these notes are convertible by the holders through the calendar quarter ended September 30, 2019. Additionally, the closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2019; therefore, these notes are convertible by the holders at any time through December 31, 2019.

⁽³⁾

Current debt as of August 29, 2019 included an aggregate of $179 million for the settlement obligation (including principal and amounts in excess of principal) for conversions of our 2033F Notes that settled in cash in the first quarter of 2020. The remainder of the 2033F Notes were classified as current as of August 29, 2019 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.

Our convertible and other senior notes are unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness and are effectively subordinated to all of our other existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness. As of August 29, 2019, Micron had $4.37 billion of unsecured debt (net of unamortized discount and debt issuance costs), including the 2024 Notes, 2025 Notes, 2026 Notes, 2027 Notes, 2029 Notes, 2030 Notes, 2032D Notes, and 2033F Notes that were structurally subordinated to all liabilities of its subsidiaries, including trade payables. The terms of our indebtedness generally contain cross payment default and cross acceleration provisions. Micron guarantees certain debt obligations of its subsidiaries but does not guarantee the MMJ Creditor Payments. Micron's guarantees of its subsidiary debt obligations are unsecured obligations ranking equally in right of payment with all of Micron's other existing and future unsecured indebtedness.

IMFT Member Debt

Pursuant to the terms of the IMFT joint venture agreement, Intel provided debt financing ("IMFT Member Debt") of $1.01 billion to IMFT in 2018. IMFT Member Debt is non-interest bearing and is convertible, at the election of Intel, in whole or in part, into a capital contribution to IMFT. Additionally, to the extent IMFT distributes cash to its members under the terms of the IMFT joint venture agreement, Intel may, at its option, designate any portion of the distribution to be a repayment of IMFT Member Debt. The remaining balance of IMFT Member Debt on October 31, 2019 will be paid by Micron upon the closing of the IMFT transaction as a component of the consideration paid to Intel for their interest in IMFT. As a result, it was classified as current as of August 29, 2019. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)

Capital Lease Obligations

In 2019, we recorded capital lease obligations aggregating $53 million at a weighted-average effective interest rate of 5.4%, with a weighted-average expected term of ten years. In 2018, we recorded capital lease obligations aggregating $20 million.

MMJ Creditor Payments

Under the MMJ Companies' corporate reorganization proceedings, which set forth the treatment of the MMJ Companies' pre-petition creditors and their claims, the MMJ Companies were required to pay 200 billion yen, less certain expenses of the reorganization proceedings and other items, to their secured and unsecured creditors in seven annual installment payments (the "MMJ Creditor Payments"). The MMJ Creditor Payments do not provide for interest and, as a result of our acquisition of the MMJ Companies in 2013, we recorded the MMJ Creditor Payments at fair value. The fair-value discount is accreted to interest expense over the term of the installment payments.

Under the MMJ Companies' corporate reorganization proceedings, the secured creditors of MMJ recovered 100% of the amount of their fixed claims in six annual installment payments through October 2018 and the unsecured creditors will recover at least 17.4% of the amount of their fixed claims in seven annual installment payments through December 2019. The remaining portion of the unsecured claims of the creditors of MMJ not recovered pursuant to the corporate reorganization proceedings will be discharged, without payment, through December 2019. The following table presents the remaining MMJ Creditor Payment (stated in Japanese yen and U.S. dollars) as of August 29, 2019:



2020	¥	21,757		$	206
Less unamortized discount	(709		)	(8		)
	¥	21,048		$	198

In 2012, we entered into a series of agreements with the corporate reorganization trustees of the MMJ Companies and the MMJ Companies, including supply agreements, research and development services agreements, and general services agreements, which are intended to generate operating cash flows to meet the requirements of the MMJ Companies' businesses, including the funding of the MMJ Creditor Payments.

Senior Unsecured Notes

Our 2024 Notes, 2025 Notes, 2026 Notes, 2027 Notes, 2029 Notes, and 2030 Notes (the "Senior Unsecured Notes") each contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock) to (1) create or incur certain liens, (2) enter into certain sale and lease-back transactions, (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity, and (4) for our 2025 Notes, create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our domestic restricted subsidiaries. These covenants are subject to a number of limitations and exceptions. If a change in control triggering event occurs, as defined in the indenture governing our Senior Unsecured Notes, we will be required to offer to purchase such notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date.

Redemption at Our Option: We may redeem the 2025 Notes, in whole or in part, at prices above the principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. We may redeem all other Senior Unsecured Notes, in whole or in part, at our option prior to their maturity at a price equal to accrued interest plus the present value of the remaining scheduled payments and we may redeem, in whole or in part, at a price equal to par between one and three months prior to maturity.

Convertible Senior Notes



	Holder Put Date⁽¹⁾	Maturity Date	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Underlying Shares of Common Stock	Conversion Value in Excess of Principal⁽³⁾		Principal Settlement Option⁽⁴⁾
2032D Notes	May 2021	May 2032	$	9.98	$	12.97	13	$	464	Cash and/or shares
2033F Notes⁽⁵⁾	Feb. 2020	Feb. 2033	10.93		14.21		6	190		Cash
							19	$	654


⁽¹⁾	Debt discount and debt issuance costs are amortized through the earliest holder put date.


⁽²⁾	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.


⁽³⁾	Based on the trading price of our common stock of $44.67 as of August 29, 2019.

⁽⁴⁾

It is our current intent to settle in cash the principal amount of our convertible notes upon conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of our convertible notes are considered in diluted earnings per share under the treasury stock method. For each of our convertible notes, we may elect to settle any amounts in excess of the principal in cash, shares of our common stock, or a combination thereof.


⁽⁵⁾	Holders may put their notes to us on February 15, 2020 and on February 15, 2023.

Conversion Rights: Holders of our convertible notes may convert their notes under the following circumstances: (1) if the notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price (see "Conversion Price Per Share Threshold" in the table above); (3) if the trading price of the notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the notes during the periods specified in the indentures; (4) if specified distributions or corporate events occur, as set forth in the indenture for the notes; or (5) during the last three months prior to the maturity date of the notes. For the calendar quarter ended September 30, 2019, the closing price of our common stock exceeded 130% of the conversion price for each series of our convertible notes; therefore, those notes are convertible by the holders through December 31, 2019.

In August 2019, holders of our 2033F Notes with an aggregate principal amount of $44 million converted their notes, which were settled in cash the first quarter of 2020. As a result of our election to settle all amounts due upon conversion in cash for these notes, such settlement obligations became derivative debt liabilities in 2019 subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the dates of our elections to settle the conversions in cash, we reclassified the fair values of the equity components of each of the converted notes from additional capital to derivative debt liabilities within current debt in our consolidated balance sheet. The net carrying amount for 2019 included $179 million for the fair values of the derivative debt liabilities as of August 29, 2019. The 20 consecutive trading day period ended in the first quarter of 2020, and we settled the conversion for $192 million in cash.

Cash Redemption at Our Option: We may redeem our convertible notes under the circumstances listed in the table below. The redemption price for the notes will equal the principal amount at maturity plus accrued and unpaid interest.



	Conditional Redemption Period at Our Option⁽¹⁾	Unconditional Redemption Period at Our Option	Redemption Period Requiring Make-Whole
2032D Notes	On or after May 1, 2017	On or after May 4, 2021	Prior to May 4, 2021⁽²⁾
2033F Notes	N/A	On or after Feb. 20, 2020	N/A


⁽¹⁾	We may redeem for cash on or after the applicable dates if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period.


⁽²⁾	If we redeem prior to the applicable date, we will pay a make-whole premium in cash equal to the present value of the remaining scheduled interest payments from the redemption date to May 4, 2021.

Cash Repurchase at the Option of the Holders: We may be required by the holders of our convertible notes to repurchase for cash all or a portion of the notes on the "Holder Put Date" listed in the table above. The repurchase price would equal the principal amount plus accrued and unpaid interest. Also, upon a change in control or a termination of trading, as defined in the respective indentures, holders of our convertible notes may require us to repurchase for cash all or a portion of their notes.

Other: Interest expense for our convertible notes consisted of contractual interest of $21 million, $44 million, and $51 million for 2019, 2018, and 2017, respectively, and amortization of discount and issuance costs of $14 million, $32 million, and $37 million for 2019, 2018, and 2017, respectively. As of August 29, 2019 and August 30, 2018, the carrying amounts of the equity components of our convertible notes, which are included in additional capital, were $29 million and $208 million, respectively.

Credit Facility

In July 2018, we entered into a credit agreement providing a committed revolving credit facility that matures in July 2023. On November 27, 2018, we amended the credit agreement to increase the amount available to draw under the revolving credit facility from $2.0 billion to $2.5 billion. On July 9, 2019, we entered into an incremental amendment to the credit agreement to obtain a term loan facility for up to $1.25 billion of financing. We suspended the security interest in the collateral under the credit agreement in 2019 upon satisfying the requirements under the credit agreement, including achieving specified credit ratings and prepayment of the 2022 Term Loan B; however, the security interest would be automatically reinstated upon a decline below a certain level in our corporate credit rating. If the security interest is reinstated, any amounts drawn under the credit agreement would be collateralized by substantially all of the assets of Micron and MSP, subject to certain permitted liens.

Borrowings under either the revolving credit facility or the term loan facility will generally bear interest at a rate equal to LIBOR plus 1.25% to 2.00%, depending on our corporate credit ratings or leverage ratio. We may elect to convert outstanding revolving or term loan interest to other variable-rate indexes. The term loan facility may be drawn in a single advance prior to November 9, 2019. If drawn, the term loan matures on the fifth anniversary of the funding date of the term loan. Principal payments are due annually in an amount equal to 5.0% of the initial aggregate principal amount with the balance due at maturity. As of August 29, 2019, there were no outstanding amounts drawn under either the revolving credit facility or the term loan facility.

Under the terms of the credit agreement, we must maintain ratios, calculated as of the last day of each fiscal quarter, of total indebtedness to adjusted EBITDA not to exceed 2.75 to 1.00 and adjusted EBITDA to net interest expense of not less than 3.50 to 1.00. The credit agreement contains other covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer, lease, or otherwise dispose of all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications.

Debt Activity

The table below presents the effects of issuances, prepayments, and conversions of debt in 2019. When we receive a notice of conversion for any of our convertible notes and elect to settle in cash any amount of the conversion obligation in excess of the principal amount, the cash settlement obligations become derivative debt liabilities subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the date of our election to settle a conversion in cash, we reclassify the fair value of the equity component of the converted notes from additional capital to derivative debt liability within current debt in our consolidated balance sheet.



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			Decrease in Equity			Gain (Loss)
Issuances
2024 Notes⁽¹⁾	$	600		$	597		$	597		$	—		$	—
2026 Notes⁽¹⁾	500			497			497			—			—
2027 Notes⁽²⁾	900			895			895			—			—
2029 Notes⁽¹⁾	700			695			695			—			—
2030 Notes⁽²⁾	850			845			845			—			—
Prepayments
2022 Term Loan B	(728		)	(721		)	(728		)	—			(7		)
Settled conversions
2032D Notes	(10		)	(9		)	(35		)	(28		)	2
2033F Notes	(45		)	(175		)	(192		)	(28		)	11
2043G Notes	(1,019		)	(691		)	(1,426		)	(326		)	(400		)
Conversions not settled
2033F Notes⁽³⁾	—			135			—			(133		)	(2		)
	$	1,748		$	2,068		$	1,148		$	(515	)	$	(396	)


⁽¹⁾	Issued February 6, 2019.


⁽²⁾	Issued July 12, 2019.


⁽³⁾	As of August 29, 2019, an aggregate of $44 million principal amount of our 2033F Notes (with a carrying value of $179 million) had converted but not settled. These notes settled in the first quarter of 2020 for $192 million in cash.

In 2018, we repurchased or redeemed $6.96 billion of principal amount of notes (carrying value of $6.93 billion) for an aggregate of $9.42 billion in cash and 4 million shares of our treasury stock. As of August 30, 2018, an aggregate of $35 million principal amount of our 2033F Notes (with a carrying value of $165 million) had converted but not settled. These notes settled in 2019 for $153 million in cash and the effect of the settlement is included in the table above. In connection with these transactions, we recognized aggregate non-operating losses of $385 million in 2018.

In 2017, we repurchased or redeemed $1.55 billion of principal amount of notes (carrying value of $1.54 billion) for an aggregate of $1.63 billion in cash. In connection with these transactions, we recognized aggregate non-operating losses of $94 million in 2017.

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 29, 2019, maturities of notes payable (including the MMJ Creditor Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2020	$	1,095		$	248
2021	134			107
2022	—			73
2023	—			48
2024	600			37
2025 and thereafter	3,469			189
Unamortized discounts and interest, respectively	(38		)	(111		)
	$	5,260		$	591

Commitments

12 Months Ended

Aug. 29, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments

As of August 29, 2019, we had commitments of approximately $7.6 billion of purchase obligations, a substantial majority of which will be due within five years. Purchase obligations include payments for the acquisition of property, plant, and equipment, and other goods or services of either a fixed or minimum quantity.

We lease certain facilities and equipment under operating leases, for which expense was $93 million, $63 million, and $52 million for 2019, 2018, and 2017, respectively. Minimum future operating lease commitments as of August 29, 2019 were as follows:



2020	$	54
2021	64
2022	63
2023	59
2024	53
2025 and thereafter	459
	$	752

Contingencies	12 Months Ended
Contingencies	Aug. 29, 2019
Loss Contingency [Abstract]
Contingencies	Contingencies We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. On August 12, 2014, MLC Intellectual Property, LLC filed a patent infringement action against Micron in the United States District Court for the Northern District of California. The complaint alleges that Micron infringes a single U.S. patent and seeks damages, attorneys' fees, and costs. On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron; Micron Semiconductor Products, Inc.; and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe 13 U.S. patents and seeks damages, attorneys' fees, and costs. On December 15, 2014, Innovative Memory Solutions, Inc. ("IMS") filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On July 23, 2018, IMS served a patent infringement complaint on Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited in the Regional Court, Mannheim, Germany alleging that products including our SSDs infringe a European patent. The complaint seeks unspecified damages and an order forbidding Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited from offering to sell, using, and importing the accused products. On June 7, 2019, the Regional Court found no infringement and dismissed the case. On August 31, 2018, Micron was served with a complaint filed by IMS in Shenzhen Intermediate People's Court in Guangdong Province, China. The complaint alleges that certain of our NAND flash products infringe a Chinese patent. The complaint seeks an order requiring Micron to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 1 million Chinese yuan plus expenses. On March 19, 2018, Micron Semiconductor (Xi'an) Co., Ltd. ("MXA") was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. ("Jinhua") in the Fuzhou Intermediate People's Court in Fujian Province, China (the "Fuzhou Court"). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. ("MSS") was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation ("UMC") in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred. On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages for each complaint of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips. On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistic-branded DRAM modules and solid-state drives in China. The affected products make up slightly more than 1% of our annualized revenues. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision. Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for a significant portion of our revenue. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately 18% of Inotera's outstanding shares as of August 29, 2019, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. On April 17, 2014, Micron and Micron B.V. filed a notice of appeal with the German Appeals Court challenging the District Court's decision. After opening briefs, the Appeals Court held a hearing on the matter on July 9, 2015, and thereafter appointed two independent experts to perform an evaluation of Dr. Jaffé's claims that the amount Micron paid for Qimonda was less than fair market value. On January 25, 2018, the court-appointed experts issued their report concluding that the amount paid by Micron was within an acceptable fair-value range. The Appeals Court held a subsequent hearing on April 30, 2019, and on May 28, 2019, the Appeals Court remanded the case to the experts for supplemental expert opinion. Antitrust Matters On April 27, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, two substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of indirect purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. On September 3, 2019, the District Court granted Micron's motion to dismiss and allowed plaintiffs the opportunity to file an amended complaint. On June 26, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, four substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of direct purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief. Additionally, six cases have been filed in the following Canadian courts: Superior Court of Quebec, the Federal Court of Canada, the Ontario Superior Court of Justice, and the Supreme Court of British Columbia. The substantive allegations in these cases are similar to those asserted in the cases filed in the United States. On May 15, 2018, the Chinese State Administration for Market Regulation ("SAMR") notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Securities Matters On January 23, 2019, a complaint was filed against Micron and two of our officers, Sanjay Mehrotra and David Zinsner, in the U.S. District Court for the Southern District of New York. The lawsuit purports to be brought on behalf of a class of purchasers of our stock during the period from June 22, 2018 through November 19, 2018. Subsequently two substantially similar cases were filed in the same court adding one of our former officers, Ernie Maddock, as a defendant and alleging a class action period from September 26, 2017 through November 19, 2018. The separate cases were joined, and a consolidated amended complaint was filed on June 15, 2019. The consolidated amended complaint alleges that defendants committed securities fraud through misrepresentations and omissions about purported anticompetitive behavior in the DRAM industry and seek compensatory and punitive damages, fees, interest, costs, and other appropriate relief. On October 2, 2019, the parties submitted a joint stipulation to dismiss the complaint. The Court approved the stipulation and dismissed the complaint on October 3, 2019. On March 5, 2019, a shareholder derivative complaint was filed in the U.S. District Court for the District of Delaware, allegedly on behalf of and for the benefit of Micron, against certain current and former officers and directors of Micron for alleged breaches of their fiduciary duties and other violations of law. The allegations are based on, among other things, purported false and misleading statements regarding anticompetitive behavior in the DRAM industry. The complaint seeks damages, fees, interest, costs, and other appropriate relief. Similar shareholder derivative complaints have subsequently been filed in the U.S. District Court for the District of Delaware and the U.S. District Court for the District of Idaho. Other On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California's Uniform Trade Secrets Act by misappropriating Micron's trade secrets and other misconduct. Micron's complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief. On June 13, 2019, current Micron employee Chris Manning filed a putative class action lawsuit on behalf of Micron employees subject to the Idaho Claim Act who earned a performance-based bonus after the conclusion of fiscal year 2018 whose performance rating was calculated based upon a mandatory percentage distribution range of performance ratings. On behalf of himself and the putative class, Manning asserts claims for violation of the Idaho Wage Claim Act, breach of contract, breach of the covenant of good faith and fair dealing, and fraud. In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. We are unable to predict the outcome of the patent matters, the Qimonda matter, antitrust matters, securities matters, and other matters noted above and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Redeemable Convertible Notes	12 Months Ended
Redeemable Convertible Notes	Aug. 29, 2019
Temporary Equity [Abstract]
Redeemable Convertible Notes	Redeemable Convertible Notes Under the terms of the indentures governing our 2033F Notes, upon conversion, we would be required to pay cash equal to the lesser of (1) the aggregate principal amount or (2) the conversion value of the notes being converted. To the extent the conversion value exceeds the principal amount, we could pay cash, shares of common stock, or a combination thereof, at our option, for the amount of such excess. The closing price of our common stock met the threshold for conversion and our 2033F Notes were convertible by their holders as of August 29, 2019 and August 30, 2018. As a result, the balance of these notes was classified as current debt and the difference between the principal amount and the carrying value was classified as redeemable convertible notes.

Redeemable Noncontrolling Interest	12 Months Ended
Redeemable Noncontrolling Interest	Aug. 29, 2019
Noncontrolling Interest [Abstract]
Redeemable Noncontrolling Interest	Redeemable Noncontrolling Interest Redeemable noncontrolling interest reflects 100,000 preferred shares authorized and issued by Micron Semiconductor Asia Operations Pte. Ltd. ("MSAO") in 2018 for proceeds, net of issuance related costs, of $97 million. Holders of the preferred shares are entitled to receive a cumulative dividend of 7.75% per annum, to be paid from the profits of MSAO on the last day of each quarter and a liquidation preference senior to MSAO's common shares. We recognize the accrued dividend in net income attributable to noncontrolling interests. Holders may require us to purchase their shares after August 29, 2028, and we have the right to reacquire the shares during the period beginning August 31, 2020 through August 29, 2026, each for par value per share plus accrued dividends.

Equity

12 Months Ended

Aug. 29, 2019

Equity [Abstract]

Equity

Micron Shareholders' Equity

Common Stock Repurchases: Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock beginning in fiscal 2019. We may purchase shares on a discretionary basis through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans, subject to market conditions and our ongoing determination of the best use of available cash. The repurchase authorization does not obligate us to acquire any common stock. In 2019, we repurchased 67 million shares of our common stock for $2.66 billion under an accelerated share repurchase agreement, Rule 10b5-1 plans, and through open market repurchases. The shares were recorded as treasury stock.

Common Stock Issuance: In 2018, we issued 34 million shares of our common stock for $41.00 per share in a public offering, for net proceeds of $1.36 billion, net of underwriting fees and other offering costs.

Treasury Stock: In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya for $986 million in cash, of which 54 million shares were issued from treasury stock. As a result, in 2017, treasury stock decreased by $1.03 billion while retained earnings decreased by $104 million for the difference between the carrying value of the treasury stock and its $925 million fair value.

Outstanding Capped Calls: In connection with our 2033F Notes, we entered into the 2033F Capped Calls, which cover, subject to anti-dilution adjustments similar to those contained in the 2033F Notes, 27 million shares of common stock and are intended to reduce the effect of potential dilution. The 2033F Capped Calls have an initial strike price of $10.93, subject to certain adjustments, which equals the conversion price of the 2033F Notes, a cap price of $14.51, and provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above the strike prices on the expiration dates. The 2033F Capped Calls expire on various dates between January 2020 and February 2020. As of August 29, 2019, the dollar value of cash or shares that we would receive from our 2033F Capped Calls upon their expiration dates range from $0, if the trading price of our stock is below the strike prices at expiration, to $98 million, if the trading price of our stock is at or above the cap prices. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration.

Expiration of Capped Calls: In 2018, we share-settled certain capped calls upon their expirations, and received 9 million shares, equal to a value of $429 million. In 2017, we cash-settled and share-settled certain capped calls upon their expirations, and received $125 million in cash and 4 million shares, equal to a value of $67 million. The amounts received upon settlement were based on volume-weighted-average trading prices of our stock at the expiration dates. The shares received in all periods were recorded as treasury stock.

Accumulated Other Comprehensive Income: Changes in accumulated other comprehensive by component for the year ended August 29, 2019 were as follows:



	Pension Liability Adjustments			Gains (Losses) on Derivative Instruments			Cumulative Foreign Currency Translation Adjustment			Unrealized Gains (Losses) on Investments			Total
As of August 30, 2018	$	10		$	2		$	—		$	(2	)	$	10
Other comprehensive income	(13		)	(3		)	(1		)	14			(3		)
Amount reclassified out of accumulated other comprehensive income	4			—			—			(3		)	1
Tax effects	3			—			—			(2		)	1
Other comprehensive income	(6		)	(3		)	(1		)	9			(1		)
As of August 29, 2019	$	4		$	(1	)	$	(1	)	$	7		$	9

Noncontrolling Interests in Subsidiaries



As of	2019				2018
	Balance		Percentage		Balance		Percentage
IMFT	$	889	49	%	$	853	49	%
Other	—		—		17		Various
	$	889			$	870

IMFT: Since 2006, we have owned 51% of IMFT, a joint venture between us and Intel. IMFT is governed by a Board of Managers, for which the number of managers appointed by each member varies based on the members' respective ownership interests. IMFT manufactures semiconductor products exclusively for its members under a long-term supply agreement at prices approximating cost. In 2018, IMFT discontinued production of NAND and subsequent to that time manufactured 3D XPoint memory. In 2018, we announced that we and Intel will no longer jointly develop 3D XPoint technology beyond the second generation and we substantially completed this cost-sharing arrangement in the first quarter of 2020. IMFT sales to Intel were $731 million, $507 million, and $493 million for 2019, 2018, and 2017, respectively.

IMFT's capital requirements are generally determined based on an annual plan approved by the members, and capital contributions to IMFT are requested as needed. Capital requests are made to the members in proportion to their then-current ownership interest. Members may elect to not contribute their proportional share, and in such event, the contributing member may elect to contribute any amount of the capital request, either in the form of an equity contribution or member debt financing. Under the supply agreement, the members have rights and obligations to the capacity of IMFT in proportion to their investment, including member debt financing. Any capital contribution or member debt financing results in a proportionate adjustment to the sharing of output on an eight-month lag. Pursuant to the terms of the IMFT joint venture agreement, Intel provided debt financing of $1.01 billion to IMFT in 2018 and IMFT repaid $316 million to Intel in 2019. As of August 29, 2019, current debt included $693 million of IMFT Member Debt. Members pay their proportionate share of fixed costs associated with IMFT's capacity.

In January 2019, we exercised our option to acquire Intel's interest in IMFT. Subsequently, Intel set the closing date to occur on October 31, 2019, at which time IMFT will become a wholly-owned subsidiary. In the first quarter of 2020, we expect to pay Intel approximately $1.4 billion in cash for Intel's noncontrolling interest in IMFT and IMFT member debt. Pursuant to the terms of the IMFT wafer supply agreement, Intel notified us of its election to receive supply from IMFT from the closing date through April 2020 at a volume equal to approximately 50% of their volume from IMFT in the six-month period prior to closing.

Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2019		2018
Assets
Cash and equivalents	$	130	$	91
Receivables	128		126
Inventories	124		114
Other current assets	9		8
Total current assets	391		339
Property, plant, and equipment	2,235		2,641
Other noncurrent assets	38		45
Total assets	$	2,664	$	3,025

Liabilities
Accounts payable and accrued expenses	$	118	$	138
Current debt	696		20
Other current liabilities	37		9
Total current liabilities	851		167
Long-term debt	53		1,064
Other noncurrent liabilities	5		74
Total liabilities	$	909	$	1,305

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Fair Value Measurements

12 Months Ended

Aug. 29, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

Substantially all of our marketable debt and equity investments were classified as available-for-sale and carried at fair value. Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of our outstanding debt instruments (excluding the carrying value of equity and mezzanine equity components of our convertible notes) were as follows:



As of	2019				2018
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ Creditor Payments	$	5,194	$	4,937	$	2,798	$	2,741
Convertible notes	852		323		3,124		1,049

The fair values of our convertible notes were determined based on Level 2 inputs, including the trading price of our convertible notes when available, our stock price, and interest rates based on similar debt issued by parties with credit ratings similar to ours. The fair values of our other debt instruments were estimated based on Level 2 inputs, including discounted cash flows, the trading price of our notes, when available, and interest rates based on similar debt issued by parties with credit ratings similar to ours.

Other operating (income) expense, net included unrealized losses primarily from semiconductor equipment held for sale of $82 million in 2019. The fair values were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment (Level 3). As of August 29, 2019, assets held for sale were not material.

Derivative Instruments and Hedging Activities Disclosure [Abstract]

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Derivative Instruments

12 Months Ended

Aug. 29, 2019

Derivative Instruments



	Gross Notional Amount		Fair Value of
	Gross Notional Amount		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of August 29, 2019
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	146	$	1	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,871		1		(9		)
Convertible notes settlement obligation⁽³⁾			—		(179		)
			1		(188		)

			$	2	$	(188	)

As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)
Convertible notes settlement obligation⁽³⁾			—		(167		)
			14		(177		)

			$	14	$	(190	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽³⁾	Notional amounts of convertible notes settlement obligations as of August 29, 2019 and August 30, 2018 were 4 million and 3 million shares of our common stock, respectively.

Derivative Instruments with Hedge Accounting Designation

We utilize currency forward contracts that generally mature within 12 months to hedge our exposure to changes in currency exchange rates. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rates, and credit-risk spreads (Level 2). We do not use derivative instruments for speculative purposes.

Cash Flow Hedges: We utilize cash flow hedges for our exposure from changes in currency exchange rates for certain capital expenditures. We recognized losses of $3 million and $17 million and gains of $15 million for 2019, 2018, and 2017, respectively, in accumulated other comprehensive income from the effective portion of cash flow hedges. Neither the amount excluded from hedge effectiveness nor the reclassifications from accumulated other comprehensive income to earnings were material in 2019, 2018, or 2017. The amounts from cash flow hedges included in accumulated other comprehensive income that are expected to be reclassified into earnings in the next 12 months were also not material.

Fair Value Hedges: In 2018, we utilized fair value hedges for our exposure from changes in currency exchange rates for certain monetary assets and liabilities. The effects of fair value hedges on our consolidated statements of operations were as follows:



	Other Non-Operating Income (Expense)
For the year ended	2018
Loss on remeasurement of hedged assets and liabilities	$	(25	)
Gain on derivatives designated as hedged instruments	25
Amortization of amounts excluded from hedge effectiveness	(32		)
	$	(32	)

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: We generally utilize a rolling hedge strategy with currency forward contracts that mature within three months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense). For derivative instruments without hedge accounting designation, we recognized losses of $32 million, $38 million, and $45 million for 2019, 2018, and 2017, respectively.

Convertible Notes Settlement Obligations: For settlement obligations associated with our convertible notes subject to mark-to-market accounting treatment, the fair values of the underlying derivative settlement obligations were initially determined using the Black-Scholes option valuation model (Level 2), which requires inputs of stock price, expected stock-price volatility, estimated option life, risk-free interest rate, and dividend rate. The subsequent measurement amounts were based on the volume-weighted-average trading price of our common stock (Level 2). (See "Debt" note.) We recognized losses of $58 million and $124 million for 2019 and 2018, respectively, in other non-operating income (expense), net for the changes in fair value of the derivative settlement obligations. Recognized gains and losses for 2017 were not material.

Derivative Counterparty Credit Risk and Master Netting Arrangements

Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of August 29, 2019 and August 30, 2018, amounts netted under our master netting arrangements were not material.

Equity Plans

12 Months Ended

Aug. 29, 2019

Share-based Payment Arrangement [Abstract]

Equity Plans

As of August 29, 2019, 108 million shares of our common stock were available for future awards under our equity plans, including 29 million shares approved for issuance under our employee stock purchase plan ("ESPP").

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

As of August 29, 2019, there were 16 million shares of Restricted Stock Awards outstanding, 14 million of which contained only service conditions. For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth or one-third increments during each year of employment after the grant date. Restrictions lapse on Restricted Stock granted in 2019 with performance or market conditions over a three-year period if conditions are met. At the end of the performance period, the number of actual shares to be awarded will vary between 0% and 200% of target amounts, depending upon the achievement level. Restricted Stock Awards activity for 2019 is summarized as follows:



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of August 30, 2018	15		$	25.18
Granted	9		41.11
Restrictions lapsed	(6	)	24.22
Canceled	(2	)	24.79
Outstanding as of August 29, 2019	16		34.72



For the year ended	2019		2018		2017
Restricted stock award shares granted	9		4		8
Weighted-average grant-date fair value per share	$	41.11	$	42.48	$	18.77
Aggregate vesting-date fair value of shares vested	$	248	$	259	$	115

Stock Options

Our stock options are generally exercisable in increments of either one-fourth or one-third per year beginning one year from the date of grant. Stock options issued after February 2014 expire eight years from the date of grant. Options issued prior to February 2014 expire six years from the date of grant. Option activity for 2019 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of August 30, 2018	18		$	23.38
Granted	—		44.30
Exercised	(5	)	17.50
Canceled or expired	(1	)	22.60
Outstanding as of August 29, 2019	12		25.94		4.3	$	220

Exercisable as of August 29, 2019	7		$	25.37	3.7	$	143
Unvested as of August 29, 2019	5		26.94		5.5	77

The total intrinsic value was $108 million, $446 million, and $198 million for options exercised in 2019, 2018, and 2017, respectively.

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2019			2018			2017
Stock options granted	—			2			8
Weighted-average grant-date fair value per share	$	19.50		$	18.65		$	8.68
Average expected life in years	5.4			5.5			5.5
Weighted-average expected volatility	44.0		%	44.0		%	46.0		%
Weighted-average risk-free interest rate	2.9		%	2.2		%	1.8		%
Expected dividend yield	0.0		%	0.0		%	0.0		%

Stock price volatility was based on an average of historical volatility and the implied volatility derived from traded options on our stock. The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options. The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date.

Employee Stock Purchase Plan

Our employee stock purchase plan ("ESPP") was offered to substantially all employees beginning in August 2018 and permits eligible employees to purchase shares of our common stock through payroll deductions of up to 10% of their eligible compensation, subject to certain limitations. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of our common stock on either the first or last day of each six-month offering period. Compensation expense is calculated as of the beginning of the offering period as the fair value of the employees' purchase rights utilizing the Black-Scholes option valuation model and is recognized over the offering period. Assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2019			2018
Weighted-average grant-date fair value per share	$	11.60		$	14.55
Average expected life in years	0.5			0.5
Weighted-average expected volatility	45.0		%	43.0		%
Weighted-average risk-free interest rate	2.2		%	2.2		%
Expected dividend yield	0.0		%	0.0		%

Employees purchased 3 million shares of common stock for $95 million in 2019 under the ESPP.

Stock-based Compensation Expense



For the year ended	2019		2018		2017
Stock-based compensation expense by caption
Cost of goods sold	$	102	$	83	$	88
Selling, general, and administrative	73		61		75
Research and development	68		54		52
	$	243	$	198	$	215

Stock-based compensation expense by type of award
Restricted stock awards	$	178	$	140	$	144
Stock options	33		55		71
ESPP	32		3		—
	$	243	$	198	$	215

The income tax benefit related to share-based compensation was $66 million, $158 million and $97 million for 2019, 2018 and 2017, respectively. The income tax benefits related to share-based compensation for the periods presented prior to the second quarter of 2018 were offset by an increase in the U.S. valuation allowance. Stock-based compensation expense of $30 million and $19 million was capitalized and remained in inventory as of August 29, 2019 and August 30, 2018, respectively. As of August 29, 2019, $439 million of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the fourth quarter of 2023, resulting in a weighted-average period of 1.3 years.

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Aug. 29, 2019
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans We have employee retirement plans at our U.S. and international sites. Details of the more significant plans are discussed as follows: Employee Savings Plan for U.S. Employees We have a 401(k) retirement plan under which U.S. employees may contribute up to 75% of their eligible pay, subject to Internal Revenue Service annual contribution limits, to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee's annual eligible earnings. Contribution expense for the 401(k) plan was $67 million, $61 million, and $52 million in 2019, 2018, and 2017, respectively. Retirement Plans We have pension plans in various countries available to local employees which are generally government mandated. As of August 29, 2019, the projected benefit obligations of our plans were $206 million and plan assets were $195 million. As of August 30, 2018, the projected benefit obligations of our plans were $190 million and plan assets were $171 million. Pension expense was not material for 2019, 2018, or 2017.

Revenue and Contract Liabilities

12 Months Ended

Aug. 29, 2019

Revenue from Contract with Customer [Abstract]

Revenue and Contract Liabilities

Revenue by product type was as follows:



For the year ended	2019		2018		2017
DRAM	$	15,247	$	21,232	$	12,963
NAND⁽¹⁾	6,946		7,897		6,585
Other (primarily 3D XPoint memory and NOR)	1,213		1,262		774
	$	23,406	$	30,391	$	20,322


⁽¹⁾	MCP revenue is reported within NAND.

Our contract liabilities from customer advances are for advance payments received from customers to secure product in future periods. Other contract liabilities consist of amounts received in advance of satisfying performance obligations. These balances are reported within other current liabilities and other noncurrent liabilities. Revenue and interest expense associated with contract liabilities for the time value of advance payments was not material in any period presented. As of August 29, 2019, our future performance obligations beyond one year were not material. Contract liabilities were as follows:



As of	August 29, 2019		Opening Balance as of August 31, 2018
Contract liabilities from customer advances	$	61	$	235
Other contract liabilities	69		113
	$	130	$	348

Revenue recognized during 2019 from the opening balance was $273 million, primarily from shipments against customer advances, which was partially offset by new customer advances.

As of August 29, 2019, other current liabilities included $326 million for estimates of consideration payable to customers, including estimates for pricing adjustments and returns.

Research and Development	12 Months Ended
Research and Development	Aug. 29, 2019
Research and Development [Abstract]
Research and Development	Research and Development We share the cost of certain product and process development activities with development partners. Our R&D expenses were reduced by $60 million, $201 million, and $213 million for 2019, 2018, and 2017, respectively, pursuant to reimbursements under these arrangements. We have had agreements to jointly develop NAND and 3D XPoint technologies with Intel. In 2018, we and Intel agreed to independently develop subsequent generations of 3D NAND and we substantially completed this cost-sharing arrangement in the third quarter of 2019. In 2018, we announced that we and Intel will no longer jointly develop 3D XPoint technology beyond the second generation and we substantially completed this cost-sharing arrangement in the first quarter of 2020.

Other Operating (Income) Expense, Net

12 Months Ended

Aug. 29, 2019

Other Income and Expenses [Abstract]

Other Operating (Income) Expense, Net



For the year ended	2019			2018			2017
(Gain) loss on disposition of property, plant, and equipment	$	43		$	(96	)	$	(22	)
Restructure and asset impairments	(29		)	28			18
Other	35			11			5
	$	49		$	(57	)	$	1

Restructure and asset impairments primarily relate to our continued emphasis to centralize certain key functions. In addition, in 2019, we finalized the sale of our 200mm fabrication facility in Singapore and recognized restructure gains of $128 million. In 2017, we recognized net restructure gains of $15 million related to the sale of our Lexar assets; our assets associated with our 200mm fabrication facility in Singapore; and our 40% ownership interest in Tera Probe, Inc and assembly and test facility located in Akita, Japan.

Other Non-Operating Income (Expense), Net

12 Months Ended

Aug. 29, 2019

Other Nonoperating Income (Expense) [Abstract]

Other Non-Operating Income (Expense), Net



For the year ended	2019			2018			2017
Loss on debt prepayments, repurchases, and conversions	$	(396	)	$	(385	)	$	(100	)
Loss from changes in currency exchange rates	(9		)	(75		)	(74		)
Gain on remeasurement of previously-held equity interest in Inotera	—			—			71
Other	—			(5		)	(9		)
	$	(405	)	$	(465	)	$	(112	)

Income Taxes

12 Months Ended

Aug. 29, 2019

Income Tax Disclosure [Abstract]

Income Taxes

On December 22, 2017, the United States enacted comprehensive tax legislation, commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"), which imposed a one-time transition tax in 2018 (the "Repatriation Tax") and, beginning in 2019, created a new minimum tax on certain foreign earnings (the "Foreign Minimum Tax"). In connection with the provisions of the Tax Act, we made an accounting policy election to treat the Foreign Minimum Tax provision as a period cost in the period the tax is incurred. SEC Staff Accounting Bulletin No. 118 ("SAB 118") allowed the use of provisional amounts (reasonable estimates) if the analyses of the impacts of the Tax Act had not been completed when financial statements were issued. During 2019, we finalized the computations of the income tax effects of the Tax Act. As such, in accordance with SAB 118, our accounting for the effects of the Tax Act is complete.

Our income tax (provision) benefit consisted of the following:



For the year ended	2019			2018			2017
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	(67	)	$	141		$	(56	)
Foreign	7,115			14,166			5,252
	$	7,048		$	14,307		$	5,196

Income tax (provision) benefit
Current
U.S. federal	$	(36	)	$	(54	)	$	—
State	(2		)	1			(1		)
Foreign	(319		)	(374		)	(152		)
	(357		)	(427		)	(153		)
Deferred
U.S. federal	(146		)	232			—
State	91			101			—
Foreign	(281		)	(74		)	39
	(336		)	$	259		39

Income tax (provision) benefit	$	(693	)	$	(168	)	$	(114	)

The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate:



For the year ended	2019					2018					2017
U.S. federal income tax (provision) benefit at statutory rate	$	(1,480	)	21.0	%	$	(3,677	)	25.7	%	$	(1,819	)	35.0	%
Foreign tax rate differential	993			(14.1	)%	2,606			(18.2	)%	1,600			(30.8	)%
U.S. tax on foreign operations	(327		)	4.6	%	(20		)	0.1	%	(37		)	0.7	%
Repatriation Tax related to the Tax Act	(10		)	0.1	%	(1,049		)	7.3	%	—			—	%
Remeasurement of deferred tax assets and liabilities related to the Tax Act	—			—	%	(179		)	1.3	%	—			—	%
Change in valuation allowance	(40		)	0.6	%	2,079			(14.5	)%	64			(1.2	)%
State taxes, net of federal benefit	102			(1.4	)%	(84		)	0.6	%	—			—	%
Research and development tax credits	118			(1.7	)%	90			(0.6	)%	66			(1.3	)%
Other	(49		)	0.7	%	66			(0.5	)%	12			(0.2	)%
Income tax (provision) benefit	$	(693	)	9.8	%	$	(168	)	1.2	%	$	(114	)	2.2	%

Measurement period adjustments in 2019 included $47 million of benefit for the Repatriation Tax, net of adjustments related to uncertain tax positions. Provisional estimates for 2018 in the table above included $1.34 billion of benefit for the release of the valuation allowance on the net deferred tax assets of our U.S. operations and $1.03 billion of provision for the Repatriation Tax, net of adjustments related to uncertain tax positions.

We operate in a number of jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements, which expire in whole or in part at various dates through 2034, that are conditional, in part, upon meeting certain business operations and employment thresholds. The effect of tax incentive arrangements reduced our tax provision by $756 million (benefiting our diluted earnings per share by $0.66) for 2019, by $1.96 billion ($1.59 per diluted share) for 2018, and by $742 million ($0.64 per diluted share) for 2017.

A provision has been recognized for deferred taxes on undistributed earnings of non-U.S. subsidiaries to the extent that dividend payments from such companies are expected to be subject to additional foreign withholding or state income tax. As of August 29, 2019, we had a deferred tax liability of $10 million associated with our undistributed earnings. Certain non-U.S. subsidiaries had cumulative undistributed earnings of $2.84 billion that were deemed to be indefinitely reinvested. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable.

Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following:



As of	2019			2018
Deferred tax assets
Net operating loss and tax credit carryforwards	$	1,045		$	1,417
Accrued salaries, wages, and benefits	122			163
Property, plant, and equipment	80			—
Other	110			115
Gross deferred tax assets	1,357			1,695
Less valuation allowance	(277		)	(228		)
Deferred tax assets, net of valuation allowance	1,080			1,467

Deferred tax liabilities
Product and process technology	(138		)	(62		)
Property, plant, and equipment	—			(173		)
Other	(109		)	(213		)
Deferred tax liabilities	(247		)	(448		)

Net deferred tax assets	$	833		$	1,019

Reported as
Deferred tax assets	$	837		$	1,022
Deferred tax liabilities (included in other noncurrent liabilities)	(4		)	(3		)
Net deferred tax assets	$	833		$	1,019

We assess positive and negative evidence for each jurisdiction to determine whether it is more likely than not that existing deferred tax assets will be realized. As of August 29, 2019, and August 30, 2018, we had a valuation allowance of $277 million and $228 million, respectively, against our net deferred tax assets, primarily related to net operating loss carryforwards in Japan. Changes in 2019 in the valuation allowance were due to adjustments based on management's assessment of tax credits and net operating losses that are more likely than not to be realized.

As of August 29, 2019, our federal, state, and foreign net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Taiwan		Other Foreign		Total
2020 - 2024	$	—	$	48	$	969	$	309	$	4	$	1,330
2025 - 2029	—		404		524		4		12		944
2030 - 2034	—		296		—		—		—		296
2035 - 2039	5		72		—		—		—		77
Indefinite	—		1		—		241		8		250
	$	5	$	821	$	1,493	$	554	$	24	$	2,897

As of August 29, 2019, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	U.S. Federal		State		Total
2020 - 2024	$	—	$	55	$	55
2025 - 2029	—		58		58
2030 - 2034	3		113		116
2035 - 2039	350		4		354
Indefinite	—		75		75
	$	353	$	305	$	658

Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits:



For the year ended	2019			2018			2017
Beginning unrecognized tax benefits	$	261		$	327		$	304
Increases related to tax positions from prior years	124			—			—
Increases related to tax positions taken in current year	44			68			15
Decreases related to tax positions from prior years	(46		)	(126		)	—
Settlements with tax authorities	—			(8		)	(47		)
Increases due to the Inotera Acquisition	—			—			54
Other	—			—			1
Ending unrecognized tax benefits	$	383		$	261		$	327

As of August 29, 2019, gross unrecognized tax benefits were $383 million, substantially all of which would affect our effective tax rate in the future, if recognized. The amount accrued for interest and penalties related to uncertain tax positions was not material for any period presented. The resolution of tax audits or expiration of statute of limitations could also reduce our unrecognized tax benefits. Although the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months would not be material.

We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states, and various foreign jurisdictions throughout the world. Our U.S. federal and state tax returns remain open to examination for 2015 through 2019. In addition, tax returns that remain open to examination in Japan range from the years 2013 to 2019 and in Singapore and Taiwan from 2014 to 2019. We believe that adequate amounts of taxes and related interest and penalties have been provided, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations, or financial condition.

Earnings Per Share

12 Months Ended

Aug. 29, 2019

Earnings Per Share [Abstract]

Earnings Per Share



For the year ended	2019			2018		2017
Net income attributable to Micron – Basic	$	6,313		$	14,135	$	5,089
Assumed conversion of debt	(12		)	—		—
Net income attributable to Micron – Diluted	$	6,301		$	14,135	$	5,089

Weighted-average common shares outstanding – Basic	1,114			1,152		1,089
Dilutive effect of equity plans and convertible notes	29			77		65
Weighted-average common shares outstanding – Diluted	1,143			1,229		1,154

Earnings per share
Basic	$	5.67		$	12.27	$	4.67
Diluted	5.51			11.51		4.41

Listed below are the potential common shares, as of the end of the periods shown, that could dilute basic earnings per share in the future that were not included in the computation of diluted earnings per share because to do so would have been antidilutive:



For the year ended	2019	2018	2017
Equity plans	8	3	21
Convertible notes	—	—	26

Segment Information

12 Months Ended

Aug. 29, 2019

Segment Information

Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes memory products sold into client, cloud server, enterprise, graphics, and networking markets.

Mobile Business Unit ("MBU"): Includes memory products sold into smartphone and other mobile-device markets.

Storage Business Unit ("SBU"): Includes SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets as well as other discrete storage products sold in component and wafer forms to the removable storage markets and sales of 3D XPoint memory.

Embedded Business Unit ("EBU"): Includes memory and storage products sold into automotive, industrial, and consumer markets.

Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. As of August 29, 2019 and August 30, 2018, CNBU, MBU, SBU, and EBU had goodwill of $832 million, $198 million, $101 million, and $97 million, respectively.



For the year ended	2019			2018			2017
Revenue
CNBU	$	9,968		$	15,252		$	8,624
MBU	6,403			6,579			4,424
SBU	3,826			5,022			4,514
EBU	3,137			3,479			2,695
All Other	72			59			65
	$	23,406		$	30,391		$	20,322

Operating income (loss)
CNBU	$	4,645		$	9,773		$	3,755
MBU	2,606			3,033			927
SBU	(386		)	964			552
EBU	923			1,473			975
All Other	13			—			23
	7,801			15,243			6,232

Unallocated
Stock-based compensation	(243		)	(198		)	(215		)
Employee severance	(116		)	—			—
Start-up and preproduction costs	(58		)	—			—
Restructure and asset impairments	32			(28		)	(18		)
Flow-through of Inotera inventory step up	—			—			(107		)
Other	(40		)	(23		)	(24		)
	(425		)	(249		)	(364		)

Operating income	$	7,376		$	14,994		$	5,868

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2019		2018		2017
CNBU	$	1,833	$	1,755	$	1,344
MBU	1,235		1,077		926
SBU	1,555		1,295		1,083
EBU	748		603		484
All Other	27		18		13
Unallocated	26		11		11
	$	5,424	$	4,759	$	3,861

Certain Concentrations

12 Months Ended

Aug. 29, 2019

Risks and Uncertainties [Abstract]

Certain Concentrations

Markets with concentrations of revenue were approximately as follows:



For the year ended	2019		2018		2017
Mobile	25	%	20	%	20	%
Client and graphics	20	%	25	%	20	%
Enterprise and cloud server	20	%	25	%	15	%
SSDs and other storage	15	%	15	%	20	%
Automotive, industrial, and consumer	15	%	10	%	15	%

Revenue from Huawei Technologies Co. Ltd. was 12% of total revenue for 2019. Revenue from Kingston Technology Company, Inc. was 11% of total revenue for 2019 and 10% of total revenue for 2018 and 2017. No other customer exceeded 10% of our total revenue. Our sales to Huawei were included in our MBU, CNBU, SBU, and EBU segments and our sales to Kingston were included in our CNBU, MBU, and SBU segments.

We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier.

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables, share repurchase, capped call, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitoring credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our foreign currency hedges as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements. Capped call agreements expose us to credit risk to the extent the counterparties may be unable to meet the terms of the agreements. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across several major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.

Geographic Information

12 Months Ended

Aug. 29, 2019

Quarterly Financial Information Disclosure [Abstract]

Geographic Information

Revenue based on the geographic location of our customer's headquarters was as follows:



For the year ended	2019		2018		2017
United States	$	12,451	$	17,116	$	11,359
Mainland China (excluding Hong Kong)	3,595		3,607		1,539
Taiwan	2,703		3,918		2,892
Hong Kong	1,614		1,761		1,429
Other Asia Pacific	1,032		1,458		1,078
Japan	958		1,265		1,042
Other	1,053		1,266		983
	$	23,406	$	30,391	$	20,322

We ship our products to locations specified by our customers and, as a result, customers may have headquarters in one location with global supply chain and operations in other locations. Our customers may request we deliver products to countries where they own or operate production facilities or to countries where they utilize third-party subcontractors or warehouses. Based on the ship-to locations specified by our customers, revenue from sales into China (including Hong Kong) accounted for 53%, 57%, and 51% of total revenue in 2019, 2018, and 2017, respectively; revenue from sales into Taiwan accounted for 13%, 9%, and 13% of total revenue in 2019, 2018, and 2017, respectively; and revenue from sales into the United States accounted for 11%, 12%, and 14% of total revenue in 2019, 2018, and 2017, respectively.

Net property, plant, and equipment by geographic area was as follows:



As of	2019		2018
Taiwan	$	9,397	$	7,640
Singapore	7,986		6,933
Japan	5,202		3,451
United States	5,048		5,113
China	370		398
Other	237		137
	$	28,240	$	23,672

Quarterly Financial Information

12 Months Ended

Aug. 29, 2019

Quarterly Financial Information

Quarterly Financial Information (Unaudited)

(in millions, except per share amounts)



2019	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Revenue	$	4,870	$	4,788	$	5,835	$	7,913
Gross margin	1,395		1,828		2,864		4,615
Operating income	650		1,010		1,957		3,759
Net income	586		851		1,625		3,296
Net income attributable to Micron	561		840		1,619		3,293

Earnings per share
Basic	$	0.51	$	0.76	$	1.45	$	2.91
Diluted	0.49		0.74		1.42		2.81



2018	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Revenue	$	8,440	$	7,797	$	7,351	$	6,803
Gross margin	5,151		4,723		4,270		3,747
Operating income	4,377		3,953		3,567		3,097
Net income	4,326		3,823		3,311		2,678
Net income attributable to Micron	4,325		3,823		3,309		2,678

Earnings per share
Basic	$	3.73	$	3.30	$	2.86	$	2.36
Diluted	3.56		3.10		2.67		2.19

Schedule II Valuation and Qualifying Accounts

12 Months Ended

Aug. 29, 2019

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II Valuation and Qualifying Accounts

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

(in millions)

MICRON TECHNOLOGY, INC.



	Balance at Beginning of Year		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended August 29, 2019	$	228	$	40		$	9		$	277
Year ended August 30, 2018	2,321		(2,079		)	(14		)	228
Year ended August 31, 2017	2,107		(64		)	278			2,321

Amounts charged to other accounts for the year ended August 31, 2017 includes $325 million as a result of the adoption of ASU 2016-09 – Improvements to Employee Share-Based Payment Accounting.

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Aug. 29, 2019
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.
Intercompany Eliminations	Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation
Comparability of Prior Year Financial Data	Information prior to 2019 is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. See "Recently Adopted Accounting Standards" note.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019, 2018, and 2017 each contained 52 weeks. All period references are to our fiscal periods unless otherwise indicated.
Derivative and Hedging Instruments	Derivative and Hedging Instruments: We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gains or losses on derivatives is included as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For the periods presented prior to the second quarter of 2018, the ineffective and excluded portion of the realized and unrealized gain or loss was included in other non-operating income (expense). As a result of adopting Accounting Standards Update ("ASU") 2017-12, beginning in the second quarter of 2018, such amounts are included in the same line item in which the underlying transactions affect earnings. For derivative forward contracts designated as fair value hedges, hedge effectiveness is determined by the change in the fair value of the undiscounted spot rate of the forward contract. The changes in fair values of hedge instruments attributed to changes in undiscounted spot rates are recognized in other non-operating income (expense). The time value associated with hedge instruments is excluded from the assessment of the effectiveness of hedges and is recognized on a straight-line basis over the life of hedges to other non-operating income (expense). We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis.
Financial Instruments, Cash Equivalents	Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash.
Financial Instruments, Investments	Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method.
Functional Currency	Functional Currency: The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries.
Goodwill	Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year.
Non-Amortizing Intangible Assets	Goodwill and Non-Amortizing Intangible Assets: We perform an annual impairment assessment for goodwill and non-amortizing intangible assets in the fourth quarter of our fiscal year.
Government Incentives	Government Incentives: We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity.
Inventories	Inventories: Inventories are stated at the lower of average cost or net realizable value. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. When net realizable value (which requires projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories) is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of average cost or net realizable value analysis and categorize inventories primarily as memory (including DRAM, NAND, and other memory). We remove amounts from inventory and charge such amounts to cost of goods sold on an average cost basis.
Product and Process Technology	Product and Process Technology: Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of the costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Capitalized product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization.
Product Warranty	Product Warranty: We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material.
Property, Plant, and Equipment	Property, Plant, and Equipment: Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of cost or estimated fair value and are included in other noncurrent assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets.
Research and Development	Research and Development: Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Product design and other R&D costs for certain technologies may be shared with a development partner. Amounts from cost-sharing arrangements are reflected as a reduction of R&D expense.
Revenue Recognition	Revenue Recognition: Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical rates of return. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue.
Stock-based Compensation	Stock-based Compensation: Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options or conversion of share units.
Treasury Stock	Treasury Stock: Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings.
Use of Estimates	Use of Estimates: The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities (Policies)	12 Months Ended
Variable Interest Entities (Policies)	Aug. 29, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Recently Adopted Accounting Standards (Tables)

12 Months Ended

Aug. 29, 2019

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

Financial Statement Impact from Adoption of New Accounting Standards

The effects of ASC 606 to our consolidated statement of operations and balance sheet were as follows:



	Year ended August 29, 2019
	As Reported			Adjustments			Amounts Without the Effects of Adoption of ASC 606
Revenue	$	23,406		$	(40	)	$	23,366
Cost of goods sold	12,704			(70		)	12,634
Interest expense	(128		)	5			(123		)
Income tax (provision) benefit	(693		)	(19		)	(712		)
Net income attributable to Micron	6,313			16			6,329



As of August 29, 2019	As Reported		Adjustments			Amounts Without the Effects of Adoption of ASC 606
Receivables	$	3,195	$	(94	)	$	3,101
Other current assets	235		(44		)	191
Deferred tax assets	837		79			916
Accounts payable and accrued expenses	4,626		6			4,632
Other current liabilities	454		(30		)	424
Other noncurrent liabilities	452		(1		)	451
Retained earnings	30,761		(34		)	30,727

The following table summarizes the effects of adopting ASU 2016-16 and ASC 606:




	Ending Balance as of August 30, 2018		ASU 2016-16			ASC 606			Opening Balance as of August 31, 2018
Receivables	$	5,478	$	—		$	114		$	5,592
Inventories	3,595		—			(5		)	3,590
Other current assets	164		(14		)	30			180
Deferred tax assets	1,022		56			(92		)	986
Other current liabilities	521		—			(4		)	517
Other noncurrent liabilities	354		—			1			355
Retained earnings	24,395		42			50			24,487

Acquisition of Inotera (Tables) - Inotera

12 Months Ended

Aug. 29, 2019

Business Acquisition [Line Items]

Schedule of Inotera Acquisition

The allocation of purchase price to assets acquired and liabilities assumed of Inotera was as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from sale of Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

Pro Forma Information including Inotera



Year ended	August 31, 2017
Net sales	$	20,317
Net income	5,172
Net income attributable to Micron	5,171
Earnings per share
Basic	4.68
Diluted	4.42

Cash and Investments (Tables)

12 Months Ended

Aug. 29, 2019

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2019								2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,388	$	—	$	—	$	2,388	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	3,418		—		—		3,418		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposits	1,292		13		1		1,306		806		11		2		819
Corporate bonds	—		550		689		1,239		3		172		272		447
Government securities	36		149		232		417		5		63		103		171
Asset-backed securities	—		67		242		309		—		34		96		130
Commercial paper	18		24		—		42		26		16		—		42
	7,152		$	803	$	1,164	$	9,119	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	127								81
Cash, cash equivalents, and restricted cash	$	7,279							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily relates to the MMJ Creditor Payments and government incentives received prior to being earned. The restrictions lapse on the MMJ Creditor Payments upon approval by the trustees and/or Tokyo District Court and for the government incentives upon achieving certain performance conditions.

Cash and equivalents and the fair values of available-for-sale investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	2019								2018
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,388	$	—	$	—	$	2,388	$	3,223	$	—	$	—	$	3,223
Level 1⁽²⁾
Money market funds	3,418		—		—		3,418		2,443		—		—		2,443
Level 2⁽³⁾
Certificates of deposits	1,292		13		1		1,306		806		11		2		819
Corporate bonds	—		550		689		1,239		3		172		272		447
Government securities	36		149		232		417		5		63		103		171
Asset-backed securities	—		67		242		309		—		34		96		130
Commercial paper	18		24		—		42		26		16		—		42
	7,152		$	803	$	1,164	$	9,119	6,506		$	296	$	473	$	7,275
Restricted cash⁽⁴⁾	127								81
Cash, cash equivalents, and restricted cash	$	7,279							$	6,587


⁽¹⁾	The maturities of long-term marketable securities range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾


⁽⁴⁾	Restricted cash is included in other noncurrent assets and primarily relates to the MMJ Creditor Payments and government incentives received prior to being earned. The restrictions lapse on the MMJ Creditor Payments upon approval by the trustees and/or Tokyo District Court and for the government incentives upon achieving certain performance conditions.

Receivables (Tables)

12 Months Ended

Aug. 29, 2019

Receivables [Abstract]

Schedule of Receivables



As of	2019		2018
Trade receivables	$	2,778	$	5,056
Income and other taxes	242		161
Other	175		261
	$	3,195	$	5,478

Inventories (Tables)

12 Months Ended

Aug. 29, 2019

Inventory Disclosure [Abstract]

Schedule of Inventories



As of	2019		2018
Finished goods	$	757	$	815
Work in process	3,825		2,357
Raw materials and supplies	536		423
	$	5,118	$	3,595

Property, Plant, and Equipment (Tables)

12 Months Ended

Aug. 29, 2019

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant, and Equipment



As of	2019			2018
Land	$	352		$	345
Buildings (includes $528 and $483, respectively, under capital leases)	10,931			8,680
Equipment⁽¹⁾ (includes $905 and $1,336, respectively, under capital leases)	44,051			38,249
Construction in progress⁽²⁾	1,700			1,162
Software	790			655
	57,824			49,091
Accumulated depreciation (includes $733 and $868, respectively, under capital leases)	(29,584		)	(25,419		)
	$	28,240		$	23,672


⁽¹⁾	Included costs related to equipment not placed into service of $2.33 billion as of August 29, 2019 and $1.73 billion as of August 30, 2018.


⁽²⁾	Included building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets and Goodwill (Tables)

12 Months Ended

Aug. 29, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill



As of	2019					2018
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	583	$	(243	)	$	567	$	(344	)
Non-amortizing assets
In-process R&D	—		—			108		—
Total intangible assets	$	583	$	(243	)	$	675	$	(344	)

Goodwill	$	1,228				$	1,228

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Aug. 29, 2019

Payables and Accruals [Abstract]

Schedule of Accounts Payable And Accrued Expenses



As of	2019		2018
Accounts payable	$	1,677	$	1,692
Property, plant, and equipment	1,782		1,238
Salaries, wages, and benefits	695		841
Income and other taxes	309		402
Other	163		201
	$	4,626	$	4,374

Debt (Tables)

12 Months Ended

Aug. 29, 2019

Debt Disclosure [Abstract]

Schedule of Debt



As of	2019												2018
							Net Carrying Amount								Net Carrying Amount
Instrument	Stated Rate		Effective Rate		Principal		Current		Long-Term		Total⁽¹⁾		Principal		Current		Long-Term		Total⁽¹⁾
IMFT Member Debt	N/A		N/A		$	693	$	693	$	—	$	693	$	1,009	$	—	$	1,009	$	1,009
Capital lease obligations	N/A		4.30	%	591		223		368		591		846		310		536		846
MMJ Creditor Payments	N/A		9.76	%	206		198		—		198		520		$	309	183		492
2024 Notes	4.64	%	4.76	%	600		—		597		597		—		—		—		—
2025 Notes	5.50	%	5.56	%	519		—		516		516		519		—		515		515
2026 Notes	4.98	%	5.07	%	500		—		497		497		—		—		—		—
2027 Notes	4.19	%	4.27	%	900		—		895		895		—		—		—		—
2029 Notes	5.33	%	5.40	%	700		—		696		696		—		—		—		—
2030 Notes	4.66	%	4.73	%	850		—		845		845		—		—		—		—
2032D Notes⁽²⁾	3.13	%	6.33	%	134		—		127		127		143		—		132		132
2033F Notes⁽²⁾⁽³⁾	2.13	%	4.93	%	62		196		—		196		107		235		—		235
2043G Notes	3.00	%	6.76	%	—		—		—		—		1,019		—		682		682
2022 Term Loan B	4.24	%	4.65	%	—		—		—		—		735		5		720		725
					$	5,755	$	1,310	$	4,541	$	5,851	$	4,898	$	859	$	3,777	$	4,636

⁽¹⁾

⁽²⁾

⁽³⁾

Schedule of MMJ Creditor Payments

The following table presents the remaining MMJ Creditor Payment (stated in Japanese yen and U.S. dollars) as of August 29, 2019:



2020	¥	21,757		$	206
Less unamortized discount	(709		)	(8		)
	¥	21,048		$	198

Schedule of Convertible Senior Notes



	Holder Put Date⁽¹⁾	Maturity Date	Conversion Price Per Share		Conversion Price Per Share Threshold⁽²⁾		Underlying Shares of Common Stock	Conversion Value in Excess of Principal⁽³⁾		Principal Settlement Option⁽⁴⁾
2032D Notes	May 2021	May 2032	$	9.98	$	12.97	13	$	464	Cash and/or shares
2033F Notes⁽⁵⁾	Feb. 2020	Feb. 2033	10.93		14.21		6	190		Cash
							19	$	654


⁽¹⁾	Debt discount and debt issuance costs are amortized through the earliest holder put date.


⁽²⁾	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.


⁽³⁾	Based on the trading price of our common stock of $44.67 as of August 29, 2019.

⁽⁴⁾


⁽⁵⁾	Holders may put their notes to us on February 15, 2020 and on February 15, 2023.

Redemption Features of Convertible Debt



	Conditional Redemption Period at Our Option⁽¹⁾	Unconditional Redemption Period at Our Option	Redemption Period Requiring Make-Whole
2032D Notes	On or after May 1, 2017	On or after May 4, 2021	Prior to May 4, 2021⁽²⁾
2033F Notes	N/A	On or after Feb. 20, 2020	N/A


⁽¹⁾	We may redeem for cash on or after the applicable dates if the volume weighted average price of our common stock has been at least 130% of the conversion price for at least 20 trading days during any 30 consecutive trading day period.


⁽²⁾	If we redeem prior to the applicable date, we will pay a make-whole premium in cash equal to the present value of the remaining scheduled interest payments from the redemption date to May 4, 2021.

Debt Issuances, Prepayments, Repurchases, and Conversions



	Increase (Decrease) in Principal			Increase (Decrease) in Carrying Value			Increase (Decrease) in Cash			Decrease in Equity			Gain (Loss)
Issuances
2024 Notes⁽¹⁾	$	600		$	597		$	597		$	—		$	—
2026 Notes⁽¹⁾	500			497			497			—			—
2027 Notes⁽²⁾	900			895			895			—			—
2029 Notes⁽¹⁾	700			695			695			—			—
2030 Notes⁽²⁾	850			845			845			—			—
Prepayments
2022 Term Loan B	(728		)	(721		)	(728		)	—			(7		)
Settled conversions
2032D Notes	(10		)	(9		)	(35		)	(28		)	2
2033F Notes	(45		)	(175		)	(192		)	(28		)	11
2043G Notes	(1,019		)	(691		)	(1,426		)	(326		)	(400		)
Conversions not settled
2033F Notes⁽³⁾	—			135			—			(133		)	(2		)
	$	1,748		$	2,068		$	1,148		$	(515	)	$	(396	)

Maturities of Notes Payable and Future Minimum Lease Payments

As of August 29, 2019, maturities of notes payable (including the MMJ Creditor Payments) and future minimum lease payments under capital lease obligations were as follows:



	Notes Payable			Capital Lease Obligations
2020	$	1,095		$	248
2021	134			107
2022	—			73
2023	—			48
2024	600			37
2025 and thereafter	3,469			189
Unamortized discounts and interest, respectively	(38		)	(111		)
	$	5,260		$	591

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Commitments and Contingencies Disclosure [Abstract]

Commitments (Tables)

12 Months Ended

Aug. 29, 2019

Schedule of Minimum Future Operating Lease Commitments

Minimum future operating lease commitments as of August 29, 2019 were as follows:



2020	$	54
2021	64
2022	63
2023	59
2024	53
2025 and thereafter	459
	$	752

Equity (Tables)

12 Months Ended

Aug. 29, 2019

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)



	Pension Liability Adjustments			Gains (Losses) on Derivative Instruments			Cumulative Foreign Currency Translation Adjustment			Unrealized Gains (Losses) on Investments			Total
As of August 30, 2018	$	10		$	2		$	—		$	(2	)	$	10
Other comprehensive income	(13		)	(3		)	(1		)	14			(3		)
Amount reclassified out of accumulated other comprehensive income	4			—			—			(3		)	1
Tax effects	3			—			—			(2		)	1
Other comprehensive income	(6		)	(3		)	(1		)	9			(1		)
As of August 29, 2019	$	4		$	(1	)	$	(1	)	$	7		$	9

Schedule Of Noncontrolling Interests In Subsidiaries



As of	2019				2018
	Balance		Percentage		Balance		Percentage
IMFT	$	889	49	%	$	853	49	%
Other	—		—		17		Various
	$	889			$	870

Schedule of IMFT Assets and Liabilities

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	2019		2018
Assets
Cash and equivalents	$	130	$	91
Receivables	128		126
Inventories	124		114
Other current assets	9		8
Total current assets	391		339
Property, plant, and equipment	2,235		2,641
Other noncurrent assets	38		45
Total assets	$	2,664	$	3,025

Liabilities
Accounts payable and accrued expenses	$	118	$	138
Current debt	696		20
Other current liabilities	37		9
Total current liabilities	851		167
Long-term debt	53		1,064
Other noncurrent liabilities	5		74
Total liabilities	$	909	$	1,305

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Estimated fair value and carrying value of debt instruments

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details

Fair Value Measurements (Tables)

12 Months Ended

Aug. 29, 2019

Fair Value Disclosures [Abstract]



As of	2019				2018
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ Creditor Payments	$	5,194	$	4,937	$	2,798	$	2,741
Convertible notes	852		323		3,124		1,049

Derivative Instruments (Tables)

12 Months Ended

Aug. 29, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments



	Gross Notional Amount		Fair Value of
	Gross Notional Amount		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of August 29, 2019
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	146	$	1	$	—

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,871		1		(9		)
Convertible notes settlement obligation⁽³⁾			—		(179		)
			1		(188		)

			$	2	$	(188	)

As of August 30, 2018
Derivative instruments with hedge accounting designation
Cash flow currency hedges	$	538	$	—	$	(13	)

Derivative instruments without hedge accounting designation
Non-designated currency hedges	1,919		14		(10		)
Convertible notes settlement obligation⁽³⁾			—		(167		)
			14		(177		)

			$	14	$	(190	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.


⁽³⁾	Notional amounts of convertible notes settlement obligations as of August 29, 2019 and August 30, 2018 were 4 million and 3 million shares of our common stock, respectively.

Schedule of Gains and Losses on Fair Value Hedges

The effects of fair value hedges on our consolidated statements of operations were as follows:



	Other Non-Operating Income (Expense)
For the year ended	2018
Loss on remeasurement of hedged assets and liabilities	$	(25	)
Gain on derivatives designated as hedged instruments	25
Amortization of amounts excluded from hedge effectiveness	(32		)
	$	(32	)

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959

Share-based Payment Arrangement [Abstract]

Equity Plans (Tables)

12 Months Ended

Aug. 29, 2019

Schedule of Restricted Stock Awards Activity



	Number of Shares		Weighted-Average Grant Date Fair Value Per Share
Outstanding as of August 30, 2018	15		$	25.18
Granted	9		41.11
Restrictions lapsed	(6	)	24.22
Canceled	(2	)	24.79
Outstanding as of August 29, 2019	16		34.72



For the year ended	2019		2018		2017
Restricted stock award shares granted	9		4		8
Weighted-average grant-date fair value per share	$	41.11	$	42.48	$	18.77
Aggregate vesting-date fair value of shares vested	$	248	$	259	$	115

Schedule of Option Activity

Option activity for 2019 is summarized as follows:



	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life (In Years)	Aggregate Intrinsic Value
Outstanding as of August 30, 2018	18		$	23.38
Granted	—		44.30
Exercised	(5	)	17.50
Canceled or expired	(1	)	22.60
Outstanding as of August 29, 2019	12		25.94		4.3	$	220

Exercisable as of August 29, 2019	7		$	25.37	3.7	$	143
Unvested as of August 29, 2019	5		26.94		5.5	77

Stock Options Granted and Valuation Assumptions

Stock options granted and assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2019			2018			2017
Stock options granted	—			2			8
Weighted-average grant-date fair value per share	$	19.50		$	18.65		$	8.68
Average expected life in years	5.4			5.5			5.5
Weighted-average expected volatility	44.0		%	44.0		%	46.0		%
Weighted-average risk-free interest rate	2.9		%	2.2		%	1.8		%
Expected dividend yield	0.0		%	0.0		%	0.0		%

Employee Stock Purchase Plan Valuation Assumptions

Assumptions used in the Black-Scholes option valuation model were as follows:



For the year ended	2019			2018
Weighted-average grant-date fair value per share	$	11.60		$	14.55
Average expected life in years	0.5			0.5
Weighted-average expected volatility	45.0		%	43.0		%
Weighted-average risk-free interest rate	2.2		%	2.2		%
Expected dividend yield	0.0		%	0.0		%

Stock-based Compensation Expense by Caption



For the year ended	2019		2018		2017
Stock-based compensation expense by caption
Cost of goods sold	$	102	$	83	$	88
Selling, general, and administrative	73		61		75
Research and development	68		54		52
	$	243	$	198	$	215

Stock-based compensation expense by type of award
Restricted stock awards	$	178	$	140	$	144
Stock options	33		55		71
ESPP	32		3		—
	$	243	$	198	$	215

Revenue and Contract Liabilities (Tables)

12 Months Ended

Aug. 29, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

Revenue by product type was as follows:



For the year ended	2019		2018		2017
DRAM	$	15,247	$	21,232	$	12,963
NAND⁽¹⁾	6,946		7,897		6,585
Other (primarily 3D XPoint memory and NOR)	1,213		1,262		774
	$	23,406	$	30,391	$	20,322


⁽¹⁾	MCP revenue is reported within NAND.

Schedule of Product Sales



For the year ended	2019		2018		2017
DRAM	$	15,247	$	21,232	$	12,963
NAND⁽¹⁾	6,946		7,897		6,585
Other (primarily 3D XPoint memory and NOR)	1,213		1,262		774
	$	23,406	$	30,391	$	20,322


⁽¹⁾	MCP revenue is reported within NAND.

Contract Liabilities



As of	August 29, 2019		Opening Balance as of August 31, 2018
Contract liabilities from customer advances	$	61	$	235
Other contract liabilities	69		113
	$	130	$	348

Other Operating (Income) Expense, Net (Tables)

12 Months Ended

Aug. 29, 2019

Other Income and Expenses [Abstract]

Schedule of Other Operating (Income) Expense, Net



For the year ended	2019			2018			2017
(Gain) loss on disposition of property, plant, and equipment	$	43		$	(96	)	$	(22	)
Restructure and asset impairments	(29		)	28			18
Other	35			11			5
	$	49		$	(57	)	$	1

Other Non-Operating Income (Expense), Net (Tables)

12 Months Ended

Aug. 29, 2019

Other Nonoperating Income (Expense) [Abstract]

Schedule of Other Nonoperating Income (Expense), Net



For the year ended	2019			2018			2017
Loss on debt prepayments, repurchases, and conversions	$	(396	)	$	(385	)	$	(100	)
Loss from changes in currency exchange rates	(9		)	(75		)	(74		)
Gain on remeasurement of previously-held equity interest in Inotera	—			—			71
Other	—			(5		)	(9		)
	$	(405	)	$	(465	)	$	(112	)

Income Taxes (Tables)

12 Months Ended

Aug. 29, 2019

Income Tax Disclosure [Abstract]

Schedule of Income (loss) Before Tax and Other Items

Our income tax (provision) benefit consisted of the following:



For the year ended	2019			2018			2017
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	(67	)	$	141		$	(56	)
Foreign	7,115			14,166			5,252
	$	7,048		$	14,307		$	5,196

Income tax (provision) benefit
Current
U.S. federal	$	(36	)	$	(54	)	$	—
State	(2		)	1			(1		)
Foreign	(319		)	(374		)	(152		)
	(357		)	(427		)	(153		)
Deferred
U.S. federal	(146		)	232			—
State	91			101			—
Foreign	(281		)	(74		)	39
	(336		)	$	259		39

Income tax (provision) benefit	$	(693	)	$	(168	)	$	(114	)

Schedule of Components of Income Tax (Provision) Benefit

Our income tax (provision) benefit consisted of the following:



For the year ended	2019			2018			2017
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$	(67	)	$	141		$	(56	)
Foreign	7,115			14,166			5,252
	$	7,048		$	14,307		$	5,196

Income tax (provision) benefit
Current
U.S. federal	$	(36	)	$	(54	)	$	—
State	(2		)	1			(1		)
Foreign	(319		)	(374		)	(152		)
	(357		)	(427		)	(153		)
Deferred
U.S. federal	(146		)	232			—
State	91			101			—
Foreign	(281		)	(74		)	39
	(336		)	$	259		39

Income tax (provision) benefit	$	(693	)	$	(168	)	$	(114	)

Schedule of Effective Income Tax Reconciliation

The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate:



For the year ended	2019					2018					2017
U.S. federal income tax (provision) benefit at statutory rate	$	(1,480	)	21.0	%	$	(3,677	)	25.7	%	$	(1,819	)	35.0	%
Foreign tax rate differential	993			(14.1	)%	2,606			(18.2	)%	1,600			(30.8	)%
U.S. tax on foreign operations	(327		)	4.6	%	(20		)	0.1	%	(37		)	0.7	%
Repatriation Tax related to the Tax Act	(10		)	0.1	%	(1,049		)	7.3	%	—			—	%
Remeasurement of deferred tax assets and liabilities related to the Tax Act	—			—	%	(179		)	1.3	%	—			—	%
Change in valuation allowance	(40		)	0.6	%	2,079			(14.5	)%	64			(1.2	)%
State taxes, net of federal benefit	102			(1.4	)%	(84		)	0.6	%	—			—	%
Research and development tax credits	118			(1.7	)%	90			(0.6	)%	66			(1.3	)%
Other	(49		)	0.7	%	66			(0.5	)%	12			(0.2	)%
Income tax (provision) benefit	$	(693	)	9.8	%	$	(168	)	1.2	%	$	(114	)	2.2	%

Schedule of Deferred Tax Assets and Liabilities



As of	2019			2018
Deferred tax assets
Net operating loss and tax credit carryforwards	$	1,045		$	1,417
Accrued salaries, wages, and benefits	122			163
Property, plant, and equipment	80			—
Other	110			115
Gross deferred tax assets	1,357			1,695
Less valuation allowance	(277		)	(228		)
Deferred tax assets, net of valuation allowance	1,080			1,467

Deferred tax liabilities
Product and process technology	(138		)	(62		)
Property, plant, and equipment	—			(173		)
Other	(109		)	(213		)
Deferred tax liabilities	(247		)	(448		)

Net deferred tax assets	$	833		$	1,019

Reported as
Deferred tax assets	$	837		$	1,022
Deferred tax liabilities (included in other noncurrent liabilities)	(4		)	(3		)
Net deferred tax assets	$	833		$	1,019

Schedule of Net Operating Loss Carryforwards

As of August 29, 2019, our federal, state, and foreign net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Expiration	U.S. Federal		State		Japan		Taiwan		Other Foreign		Total
2020 - 2024	$	—	$	48	$	969	$	309	$	4	$	1,330
2025 - 2029	—		404		524		4		12		944
2030 - 2034	—		296		—		—		—		296
2035 - 2039	5		72		—		—		—		77
Indefinite	—		1		—		241		8		250
	$	5	$	821	$	1,493	$	554	$	24	$	2,897

Schedule of Tax Credit Carryforwards

As of August 29, 2019, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows:



Year of Tax Credit Expiration	U.S. Federal		State		Total
2020 - 2024	$	—	$	55	$	55
2025 - 2029	—		58		58
2030 - 2034	3		113		116
2035 - 2039	350		4		354
Indefinite	—		75		75
	$	353	$	305	$	658

Rollforward of Unrecognized Tax Benefits

Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits:



For the year ended	2019			2018			2017
Beginning unrecognized tax benefits	$	261		$	327		$	304
Increases related to tax positions from prior years	124			—			—
Increases related to tax positions taken in current year	44			68			15
Decreases related to tax positions from prior years	(46		)	(126		)	—
Settlements with tax authorities	—			(8		)	(47		)
Increases due to the Inotera Acquisition	—			—			54
Other	—			—			1
Ending unrecognized tax benefits	$	383		$	261		$	327

Earnings Per Share (Tables)

12 Months Ended

Aug. 29, 2019

Earnings Per Share [Abstract]

Basic and Diluted Earnings Per Share



For the year ended	2019			2018		2017
Net income attributable to Micron – Basic	$	6,313		$	14,135	$	5,089
Assumed conversion of debt	(12		)	—		—
Net income attributable to Micron – Diluted	$	6,301		$	14,135	$	5,089

Weighted-average common shares outstanding – Basic	1,114			1,152		1,089
Dilutive effect of equity plans and convertible notes	29			77		65
Weighted-average common shares outstanding – Diluted	1,143			1,229		1,154

Earnings per share
Basic	$	5.67		$	12.27	$	4.67
Diluted	5.51			11.51		4.41

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share



For the year ended	2019	2018	2017
Equity plans	8	3	21
Convertible notes	—	—	26

Segment Information (Tables)

12 Months Ended

Aug. 29, 2019

Schedule of Results by Segment



For the year ended	2019			2018			2017
Revenue
CNBU	$	9,968		$	15,252		$	8,624
MBU	6,403			6,579			4,424
SBU	3,826			5,022			4,514
EBU	3,137			3,479			2,695
All Other	72			59			65
	$	23,406		$	30,391		$	20,322

Operating income (loss)
CNBU	$	4,645		$	9,773		$	3,755
MBU	2,606			3,033			927
SBU	(386		)	964			552
EBU	923			1,473			975
All Other	13			—			23
	7,801			15,243			6,232

Unallocated
Stock-based compensation	(243		)	(198		)	(215		)
Employee severance	(116		)	—			—
Start-up and preproduction costs	(58		)	—			—
Restructure and asset impairments	32			(28		)	(18		)
Flow-through of Inotera inventory step up	—			—			(107		)
Other	(40		)	(23		)	(24		)
	(425		)	(249		)	(364		)

Operating income	$	7,376		$	14,994		$	5,868

Depreciation and amortization expense included in operating income was as follows:



For the year ended	2019		2018		2017
CNBU	$	1,833	$	1,755	$	1,344
MBU	1,235		1,077		926
SBU	1,555		1,295		1,083
EBU	748		603		484
All Other	27		18		13
Unallocated	26		11		11
	$	5,424	$	4,759	$	3,861

Certain Concentrations (Tables)

12 Months Ended

Aug. 29, 2019

Risks and Uncertainties [Abstract]

Schedule of Market Concentration Risk

Markets with concentrations of revenue were approximately as follows:



For the year ended	2019		2018		2017
Mobile	25	%	20	%	20	%
Client and graphics	20	%	25	%	20	%
Enterprise and cloud server	20	%	25	%	15	%
SSDs and other storage	15	%	15	%	20	%
Automotive, industrial, and consumer	15	%	10	%	15	%

Geographic Information (Tables)

12 Months Ended

Aug. 29, 2019

Geographic Net Sales based on Location of Customer Headquarters



For the year ended	2019		2018		2017
United States	$	12,451	$	17,116	$	11,359
Mainland China (excluding Hong Kong)	3,595		3,607		1,539
Taiwan	2,703		3,918		2,892
Hong Kong	1,614		1,761		1,429
Other Asia Pacific	1,032		1,458		1,078
Japan	958		1,265		1,042
Other	1,053		1,266		983
	$	23,406	$	30,391	$	20,322

Net Property, Plant, and Equipment by Geographic Area

Net property, plant, and equipment by geographic area was as follows:



As of	2019		2018
Taiwan	$	9,397	$	7,640
Singapore	7,986		6,933
Japan	5,202		3,451
United States	5,048		5,113
China	370		398
Other	237		137
	$	28,240	$	23,672

Quarterly Financial Information (Tables)

12 Months Ended

Aug. 29, 2019

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information



2019	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Revenue	$	4,870	$	4,788	$	5,835	$	7,913
Gross margin	1,395		1,828		2,864		4,615
Operating income	650		1,010		1,957		3,759
Net income	586		851		1,625		3,296
Net income attributable to Micron	561		840		1,619		3,293

Earnings per share
Basic	$	0.51	$	0.76	$	1.45	$	2.91
Diluted	0.49		0.74		1.42		2.81



2018	Fourth Quarter		Third Quarter		Second Quarter		First Quarter
Revenue	$	8,440	$	7,797	$	7,351	$	6,803
Gross margin	5,151		4,723		4,270		3,747
Operating income	4,377		3,953		3,567		3,097
Net income	4,326		3,823		3,311		2,678
Net income attributable to Micron	4,325		3,823		3,309		2,678

Earnings per share
Basic	$	3.73	$	3.30	$	2.86	$	2.36
Diluted	3.56		3.10		2.67		2.19

Schedule II Valuation and Qualifying Accounts (Tables)

12 Months Ended

Aug. 29, 2019

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Deferred Tax Asset Valuation Allowance



	Balance at Beginning of Year		Charged (Credited) to Income Tax Provision			Currency Translation and Charges to Other Accounts			Balance at End of Year
Deferred Tax Asset Valuation Allowance
Year ended August 29, 2019	$	228	$	40		$	9		$	277
Year ended August 30, 2018	2,321		(2,079		)	(14		)	228
Year ended August 31, 2017	2,107		(64		)	278			2,321

Significant Accounting Policies - Product and Process Technology (Details)	12 Months Ended
	Aug. 29, 2019
Maximum
Finite-Lived Intangible Assets [Line Items]
Maximum life of product and process technology intangible assets (in years)	12 years 6 months

Significant Accounting Policies - Property, Plant and Equipment (Details)	12 Months Ended
	Aug. 29, 2019
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	30 years
Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	5 years
Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	7 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	5 years

Variable Interest Entities (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 30, 2018
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract]
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of PP&E	$ 50	$ 63
Variable Interest Entity (PTI Xi'an), Nonconsolidated, Carrying Amount of Capital Leases	$ 47	$ 63

Recently Adopted Accounting Standards (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 31, 2018	Aug. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables	$ 3,195	$ 5,592	$ 5,478
Inventories	5,118	3,590	3,595
Other current assets	235	180	164
Deferred tax assets	837	986	1,022
Other current liabilities	454	517	521
Other noncurrent liabilities	452	355	354
Retained earnings	$ 30,761	24,487	$ 24,395
ASU 2016-16
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables		0
Inventories		0
Other current assets		(14)
Deferred tax assets		56
Other current liabilities		0
Other noncurrent liabilities		0
Retained earnings		42
ASC 606
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Receivables		114
Inventories		(5)
Other current assets		30
Deferred tax assets		(92)
Other current liabilities		(4)
Other noncurrent liabilities		1
Retained earnings		$ 50

Recently Adopted Accounting Standards Revenue Initial Application Period Cumulative Effect (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Aug. 29, 2019	May 30, 2019	Feb. 28, 2019	Nov. 29, 2018	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017	Aug. 31, 2018
Income Statement [Abstract]
Revenue	$ 4,870	$ 4,788	$ 5,835	$ 7,913	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 23,406	$ 30,391	$ 20,322
Cost of goods sold									12,704	12,500	11,886
Interest expense									(128)	(342)	(601)
Income tax (provision) benefit									(693)	(168)	(114)
Net income attributable to Micron	561	$ 840	$ 1,619	$ 3,293	4,325	$ 3,823	$ 3,309	$ 2,678	6,313	14,135	$ 5,089
Balance Sheet [Abstract]
Receivables	3,195				5,478				3,195	5,478		$ 5,592
Other current assets	235				164				235	164		180
Deferred tax assets	837				1,022				837	1,022		986
Accounts payable and accrued expenses	4,626				4,374				4,626	4,374
Other current liabilities	454				521				454	521		517
Other noncurrent liabilities	452				354				452	354		355
Retained earnings	30,761				$ 24,395				30,761	$ 24,395		24,487
ASC 606
Balance Sheet [Abstract]
Receivables												114
Other current assets												30
Deferred tax assets												(92)
Other current liabilities												(4)
Other noncurrent liabilities												1
Retained earnings												$ 50
Difference between Revenue Guidance in Effect before and after Topic 606 \| ASC 606
Income Statement [Abstract]
Revenue									40
Cost of goods sold									70
Interest expense									(5)
Income tax (provision) benefit									19
Net income attributable to Micron									(16)
Balance Sheet [Abstract]
Receivables	94								94
Other current assets	44								44
Deferred tax assets	(79)								(79)
Accounts payable and accrued expenses	(6)								(6)
Other current liabilities	30								30
Other noncurrent liabilities	1								1
Retained earnings	34								34
Calculated under Revenue Guidance in Effect before Topic 606 \| ASC 606
Income Statement [Abstract]
Revenue									23,366
Cost of goods sold									12,634
Interest expense									(123)
Income tax (provision) benefit									(712)
Net income attributable to Micron									6,329
Balance Sheet [Abstract]
Receivables	3,101								3,101
Other current assets	191								191
Deferred tax assets	916								916
Accounts payable and accrued expenses	4,632								4,632
Other current liabilities	424								424
Other noncurrent liabilities	451								451
Retained earnings	$ 30,727								$ 30,727

Recently Issued Accounting Standards Not Yet Adopted (Details) - ASU 2016-02 - Leases - Forecast $ in Millions	Aug. 30, 2019 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Approximate operating lease liability to be recorded upon adoption	$ 550
Approximate operating lease right-of-use asset to be recorded upon adoption	$ 550

Acquisition of Inotera (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended	12 Months Ended
	Dec. 06, 2016	Dec. 05, 2016	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017	Sep. 01, 2016
Acquisition of Inotera
Gain on remeasurement of previously-held equity interest in Inotera			$ 0	$ 0	$ 71
Consideration
Payments attributed to intercompany balances with Inotera			0	0	361
Assets acquired and liabilities assumed
Goodwill			1,228	1,228
Unaudited Pro Forma Financial Information
Net sales					20,317
Net Income					5,172
Net income attributable to Micron					$ 5,171
Earnings per share, basic (in dollars per share)					$ 4.68
Earnings per share, diluted (in dollars per share)					$ 4.42
CNBU
Assets acquired and liabilities assumed
Goodwill			832	832
MBU
Assets acquired and liabilities assumed
Goodwill			198	198
EBU
Assets acquired and liabilities assumed
Goodwill			$ 97	$ 97
Inotera \| Nanya and certain of its affiliates
Acquisition of Inotera
Percentage interest in Inotera held by Nanya immediately prior to acquisition (in hundredths)		32.00%
Inotera
Acquisition of Inotera
Ownership interest in Inotera immediately prior to acquisition (in hundredths)		33.00%
Percentage of Inotera voting interests acquired (in hundredths)	67.00%
Transaction costs incurred in connection with acquisition of Inotera					$ 13	$ 3
Gain on remeasurement of previously-held equity interest in Inotera					$ 71
Micron Shares
Proceeds from issuance of stock to Nanya	$ 986
Consideration
Cash paid for Inotera Acquisition	4,099
Less cash received from selling Micron Shares	(986)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361)
Total fair value of consideration for Inotera including previously held equity interests	5,191
Assets acquired and liabilities assumed
Cash and equivalents	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,722
Deferred tax assets	82
Goodwill	1,124
Other noncurrent assets	130
Accounts payable and accrued expenses	(232)
Debt	(56)
Other noncurrent liabilities	(9)
Total assets acquired and liabilities assumed, including goodwill	5,191
Inotera \| CNBU
Assets acquired and liabilities assumed
Goodwill	829
Inotera \| MBU
Assets acquired and liabilities assumed
Goodwill	198
Inotera \| EBU
Assets acquired and liabilities assumed
Goodwill	$ 97
Inotera \| Shares Issued to Nanya
Micron Shares
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares)	58
Proceeds from issuance of stock to Nanya	$ 986
Discount for lack of transferability on Micron Shares issued to Nanya	81
Consideration
Less cash received from selling Micron Shares	$ (986)
Inotera
Acquisition of Inotera
Pre-acquisition purchases of DRAM products from Inotera		$ 504

Cash and Investments (Details) - USD ($)
$ in Millions

12 Months Ended

Aug. 29, 2019

Aug. 30, 2018

Aug. 31, 2017

Sep. 01, 2016

Debt Securities, Available-for-sale [Line Items]

$ 7,152

$ 6,506

803

296

^[1]

1,164

473

Cash, cash equivalents, and restricted cash

9,119

7,275

Restricted cash

^[2]

127

7,279

6,587

$ 5,216

$ 4,263

Value of available-for-sale debt securities in a continuous unrealized loss position 12 months or longer

$ 0

Minimum

Debt Securities, Available-for-sale [Line Items]

General maturities of long-term marketable securities (in years)

1 year

Maximum

Debt Securities, Available-for-sale [Line Items]

General maturities of long-term marketable securities (in years)

4 years

Cash

Debt Securities, Available-for-sale [Line Items]

$ 2,388

3,223

Money market funds | Level 1

2,388

3,223

Debt Securities, Available-for-sale [Line Items]

^[3]

3,418

2,443

^[3]

^[1],[3]

Certificates of deposits | Level 2

^[3]

3,418

2,443

Debt Securities, Available-for-sale [Line Items]

^[4]

1,292

806

^[4]

^[1],[4]

Corporate bonds | Level 2

^[4]

1,306

819

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

550

172

^[1],[4]

689

272

Government securities | Level 2

^[4]

1,239

447

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

149

^[1],[4]

232

103

Asset-backed securities | Level 2

^[4]

417

171

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

^[1],[4]

242

Commercial paper | Level 2

^[4]

309

130

Debt Securities, Available-for-sale [Line Items]

^[4]

^[4]

^[1],[4]

Property, Plant and Equipment, Net, by Type [Abstract]

^[4]

$ 42

[1]	The maturities of long-term marketable securities range from one to four years.
[2]	Restricted cash is included in other noncurrent assets and primarily relates to the MMJ Creditor Payments and government incentives received prior to being earned. The restrictions lapse on the MMJ Creditor Payments upon approval by the trustees and/or Tokyo District Court and for the government incentives upon achieving certain performance conditions.
[3]	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[4]	The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of August 29, 2019 or August 30, 2018.

Receivables (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 31, 2018	Aug. 30, 2018
Receivables [Abstract]
Trade receivables	$ 2,778		$ 5,056
Income and other taxes	242		161
Other	175		261
Receivables	$ 3,195	$ 5,592	$ 5,478

Inventories (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 31, 2018	Aug. 30, 2018
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 757		$ 815
Work in process	3,825		2,357
Raw materials and supplies	536		423
Inventories	$ 5,118	$ 3,590	$ 3,595

Property, Plant, and Equipment (Details) - USD ($)
$ in Millions

12 Months Ended

Aug. 29, 2019

Aug. 30, 2018

Aug. 31, 2017

Property, plant, and equipment, net

$ 57,824

$ 49,091

Accumulated depreciation

(29,584)

(25,419)

28,240

23,672

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

Capital leased assets, accumulated depreciation

(733)

(868)

Depreciation [Abstract]

Depreciation expense

5,340

4,660

$ 3,760

Capitalized Interest Costs [Abstract]

Interest capitalized as part of the cost of property, plant, and equipment

103

$ 7

Land

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

352

345

Buildings

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

10,931

8,680

Capital leased assets, gross

528

483

Equipment

Property, Plant and Equipment, Net, by Type [Abstract]

Capital Leases, Balance Sheet, Assets by Major Class, Net [Abstract]

^[1]

44,051

38,249

Capital leased assets, gross

905

1,336

Equipment not placed into service

Property, Plant and Equipment, Net, by Type [Abstract]

Property, Plant and Equipment, Net, by Type [Abstract]

2,330

1,730

Construction in progress

Property, Plant and Equipment, Net, by Type [Abstract]

^[2]

1,700

1,162

Software

Long-term Debt, by Current and Noncurrent [Abstract]

$ 790

$ 655

[1]	Included costs related to equipment not placed into service of $2.33 billion as of August 29, 2019 and $1.73 billion as of August 30, 2018.
[2]	Included building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets and Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Amortizing assets [Line Items]
Gross Amount, Product and process technology	$ 583	$ 567
Accumulated Amortization, Product and process technology	(243)	(344)
Annual amortization expense for intangible assets [Abstract]
2020	72
2021	62
2022	50
2023	44
2024	40
Gross Amount, In-process R&D	0	108
Intangible Assets, Gross (Excluding Goodwill)	583	675
Goodwill	1,228	1,228
Product and process technology
Amortizing assets [Line Items]
Increase in amortizing intangible assets	$ 91	$ 48	$ 29
Product and process technology \| Weighted Average
Amortizing assets [Line Items]
Useful lives of assets placed into service	8 years	10 years	11 years
In-process R&D placed into service
Amortizing assets [Line Items]
Increase in amortizing intangible assets	$ 108
Useful lives of assets placed into service	6 years

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 30, 2018
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 1,677	$ 1,692
Property, plant, and equipment	1,782	1,238
Salaries, wages, and benefits	695	841
Income and other taxes	309	402
Other	163	201
Total accounts payable and accrued expenses	$ 4,626	$ 4,374

Debt - Schedule of Long-term Debt (Details)
$ / shares in Units, shares in Millions

12 Months Ended

Aug. 29, 2019

USD ($)

$ / shares

Aug. 30, 2018

USD ($)

Aug. 31, 2017

USD ($)

Nov. 27, 2018

USD ($)

$ 5,755,000,000

$ 4,898,000,000

1,310,000,000

859,000,000

4,541,000,000

3,777,000,000

^[1]

5,851,000,000

4,636,000,000

$ 3,550,000,000

1,009,000,000

$ 3,311,000,000

Share Price (in dollars per share) | $ / shares

$ 44.67

Interest Costs Incurred [Abstract]

Amortization of debt discount and issuance costs

$ 49,000,000

101,000,000

125,000,000

Micron Technology, Inc.

Long-term Debt, by Current and Noncurrent [Abstract]

Subordinated Debt

4,370,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[2]

696,000,000

20,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

^[2]

53,000,000

1,064,000,000

Convertible Debt

Derivative debt liability

135,000,000

132,000,000

Principal amount elected to be settled in cash

$ 44,000,000

35,000,000

Underlying Shares of Common Stock (in shares) | shares

Conversion Value in Excess of Principal

^[3],[4]

$ 654,000,000

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days) | d

Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths)

98.00%

Interest Costs Incurred [Abstract]

Contractual interest expense

$ 21,000,000

44,000,000

51,000,000

Amortization of debt discount and issuance costs

14,000,000

32,000,000

$ 37,000,000

Equity component of convertible debt included in additional paid in capital

29,000,000

208,000,000

Convertible Debt | IMFT Member Debt

Long-term Debt, by Current and Noncurrent [Abstract]

693,000,000

1,009,000,000

693,000,000

1,009,000,000

$ 693,000,000

1,009,000,000

Convertible Debt | 2032D Notes

1,010,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

3.13%

6.33%

$ 134,000,000

143,000,000

^[5]

127,000,000

^[5]

132,000,000

$ 127,000,000

132,000,000

Conversion Price Per Share | $ / shares

$ 9.98

Conversion Price Per Share Threshold (dollars per share) | $ / shares

^[6]

$ 12.97

Underlying Shares of Common Stock (in shares) | shares

Conversion Value in Excess of Principal

^[3],[4]

$ 464,000,000

Convertible Debt | 2033F Notes

Long-term Debt, by Current and Noncurrent [Abstract]

2.13%

4.93%

$ 62,000,000

107,000,000

196,000,000

^[5],[7]

235,000,000

^[5]

$ 196,000,000

235,000,000

Conversion Price Per Share | $ / shares

$ 10.93

Conversion Price Per Share Threshold (dollars per share) | $ / shares

^[6]

$ 14.21

Underlying Shares of Common Stock (in shares) | shares

Conversion Value in Excess of Principal

^[3],[4],[8]

$ 190,000,000

Convertible Debt | 2043G Notes

Long-term Debt, by Current and Noncurrent [Abstract]

3.00%

6.76%

$ 0

1,019,000,000

^[5]

^[5]

682,000,000

Capital lease obligations

682,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

591,000,000

846,000,000

223,000,000

310,000,000

368,000,000

536,000,000

Capital lease obligations incurred

591,000,000

846,000,000

Leases, Capital [Abstract]

$ 53,000,000

20,000,000

Capital lease obligations | Weighted Average

Long-term Debt, by Current and Noncurrent [Abstract]

Weighted-average effective interest rate

4.30%

Leases, Capital [Abstract]

5.40%

Weighted-average expected term

10 years

Reorganization obligation

Long-term Debt, by Current and Noncurrent [Abstract]

9.76%

$ 206,000,000

520,000,000

198,000,000

309,000,000

183,000,000

Subsidiary ownership percentage by parent resulting in potential activity restriction

$ 198,000,000

492,000,000

Corporate Bonds

Senior Unsecured Notes [Abstract]

80.00%

Redemption price percentage upon change in control

101.00%

Corporate Bonds | Minimum

Senior Unsecured Notes [Abstract]

Redemption option at par, period prior to maturity

1 month

Corporate Bonds | Maximum

Senior Unsecured Notes [Abstract]

Redemption option at par, period prior to maturity

3 months

Corporate Bonds | 2024 Notes

Long-term Debt, by Current and Noncurrent [Abstract]

4.64%

4.76%

$ 600,000,000

597,000,000

Corporate Bonds | 2025 Notes

$ 597,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

5.50%

5.56%

$ 519,000,000

519,000,000

516,000,000

515,000,000

Corporate Bonds | 2026 Notes

$ 516,000,000

515,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.98%

5.07%

$ 500,000,000

497,000,000

Corporate Bonds | 2027 Notes

$ 497,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.19%

4.27%

$ 900,000,000

895,000,000

Corporate Bonds | 2029 Notes

$ 895,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

5.33%

5.40%

$ 700,000,000

696,000,000

Corporate Bonds | 2030 Notes

$ 696,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.66%

4.73%

$ 850,000,000

845,000,000

Secured Debt | 2022 Term Loan B

$ 845,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

4.24%

4.65%

$ 0

735,000,000

5,000,000

720,000,000

Notes Payable, Other Payables | Credit Facility

$ 725,000,000

Long-term Debt, by Current and Noncurrent [Abstract]

Notes Payable, Other Payables | Credit Facility | LIBOR | Minimum

$ 0

Margin on variable rate financing (in hundredths)

1.25%

Notes Payable, Other Payables | Credit Facility | LIBOR | Maximum

Margin on variable rate financing (in hundredths)

2.00%

Notes Payable, Other Payables | Revolving credit facility

Line of credit facility, Maximum borrowing capacity

$ 2,500,000,000

$ 2,000,000,000

Debt Covenant, Ratio Of Total Debt To Adjusted EBITDA

2.75

Debt Covenant, Ratio of Adjusted EBITDA to Net Interest Expense

3.5

Notes Payable, Other Payables | Term loan facility

Line of credit facility, Maximum borrowing capacity

$ 1,250,000,000

Percentage of original principal to be repaid annually

5.00%

[1]	Net carrying amount is the principal amount less unamortized debt discount and issuance costs. In addition, the net carrying amount as of August 29, 2019 and August 30, 2018 included $135 million and $132 million, respectively, of derivative debt liabilities recognized as a result of our election to settle entirely in cash converted notes with an aggregate principal amount of $44 million and $35 million, respectively.
[2]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
[3]	Based on the trading price of our common stock of $44.67 as of August 29, 2019.
[4]	It is our current intent to settle in cash the principal amount of our convertible notes upon conversion. As a result, only the amounts payable in excess of the principal amounts upon conversion of our convertible notes are considered in diluted earnings per share under the treasury stock method. For each of our convertible notes, we may elect to settle any amounts in excess of the principal in cash, shares of our common stock, or a combination thereof.
[5]	Since the closing price of our common stock exceeded 130% of the conversion price per share for at least 20 trading days in the 30 trading day period ended on June 30, 2019, these notes are convertible by the holders through the calendar quarter ended September 30, 2019. Additionally, the closing price of our common stock also exceeded the thresholds for the calendar quarter ended September 30, 2019; therefore, these notes are convertible by the holders at any time through December 31, 2019.
[6]	Represents 130% of the conversion price per share. If the trading price of our common stock exceeds such threshold for a specified period, holders may convert such notes during a specified period. See "Conversion Rights" below.
[7]	Current debt as of August 29, 2019 included an aggregate of $179 million for the settlement obligation (including principal and amounts in excess of principal) for conversions of our 2033F Notes that settled in cash in the first quarter of 2020. The remainder of the 2033F Notes were classified as current as of August 29, 2019 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.
[8]	Holders may put their notes to us on February 15, 2020 and on February 15, 2023.

Debt - MMJ Creditor Payments (Details)
¥ in Millions, $ in Millions

Aug. 29, 2019

USD ($)

payment

Aug. 29, 2019

JPY (¥)

payment

Aug. 30, 2018

USD ($)

Reorganization obligation

Debt | $

$ 5,851

^[1]

$ 4,636

^[1]

Reorganization obligation | Micron Memory Japan, Inc.

Debt | $

$ 198

$ 492

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Total MMJ Creditor Payments | ¥

¥ 200,000

Number of periodic MMJ creditor installment payments

Less unamortized discount

$ (8)

¥ (709)

Debt

198

21,048

Reorganization obligation | Micron Memory Japan, Inc. | Scenario, Plan

Reorganization obligation | Micron Memory Japan, Inc. | Secured Creditors

2020

$ 206

¥ 21,757

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Number of periodic MMJ creditor installment payments

Recovery Rate of Reorganization Plan Creditors

100.00%

Reorganization obligation | Micron Memory Japan, Inc. | Unsecured Creditors

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Number of periodic MMJ creditor installment payments

Reorganization obligation | Micron Memory Japan, Inc. | Unsecured Creditors | Minimum

Troubled Debt Restructuring, Debtor, Subsequent Periods [Line Items]

Recovery Rate of Reorganization Plan Creditors

17.40%

[1]

Debt - Debt Activity (Details) - USD ($)
shares in Millions, $ in Millions

3 Months Ended

12 Months Ended

Nov. 28, 2019

Nov. 29, 2018

Aug. 29, 2019

Aug. 30, 2018

Aug. 31, 2017

$ 1,748

$ (6,960)

2,068

(6,930)

Increase (Decrease) in Cash

(9,420)

1,148

Gain (Loss) on debt prepayments, repurchases, and conversions

(515)

(2,243)

$ (33)

(396)

$ (385)

(100)

Treasury shares issued for conversion

Loss on debt prepayments, repurchases, and conversions

1,310

$ 859

(396)

(385)

(99)

Secured Debt | 2022 Term Loan B

(728)

(721)

Gain (Loss) on debt prepayments, repurchases, and conversions

(728)

$ (7)

Convertible Debt

Derivative, Term of Contract (in consecutive trading days)

20 days

Convertible Debt | 2032D Notes

$ (10)

(9)

(35)

Gain (Loss) on debt prepayments, repurchases, and conversions

(28)

Convertible Debt | 2033F Notes

(45)

(175)

$ (153)

(192)

Gain (Loss) on debt prepayments, repurchases, and conversions

(28)

Convertible Debt | 2033F Notes | Conversions not settled

^[1]

^[1]

135

^[1]

Gain (Loss) on debt prepayments, repurchases, and conversions

^[1]

(133)

^[1]

(2)

Principal amount of settlement obligations to be settled in cash in a future period

Convertible Debt | 2043G Notes

179

165

(1,019)

(691)

(1,426)

Gain (Loss) on debt prepayments, repurchases, and conversions

(326)

(400)

Corporate Bonds

(1,550)

(1,540)

Loss on debt prepayments, repurchases, and conversions

(1,630)

$ (94)

Subsequent Event | Convertible Debt | 2033F Notes

Corporate Bonds | 2024 Notes

$ (192)

^[2]

600

^[2]

597

^[2]

597

Corporate Bonds | 2026 Notes

^[2]

500

^[2]

497

^[2]

497

Corporate Bonds | 2027 Notes

^[3]

900

^[3]

895

^[3]

895

Corporate Bonds | 2029 Notes

^[2]

700

^[2]

695

^[2]

695

Corporate Bonds | 2030 Notes

^[3]

850

^[3]

845

^[3]

845

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

$ 0

[1]	As of August 29, 2019, an aggregate of $44 million principal amount of our 2033F Notes (with a carrying value of $179 million) had converted but not settled. These notes settled in the first quarter of 2020 for $192 million in cash.
[2]	Issued February 6, 2019.
[3]	Issued July 12, 2019.

Debt - Maturities (Details) $ in Millions	Aug. 29, 2019 USD ($)
Capital Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
2020	$ 248
2021	107
2022	73
2023	48
2024	37
2025 and thereafter	189
Capital Leases, Future Minimum Payments, Interest Included in Payments	(111)
Capital Lease Obligations	591
Notes Payable (including MMJ Creditor Payments)
Long-term Debt, by Maturity [Abstract]
2020	1,095
2021	134
2022	0
2023	0
2024	600
2025 and thereafter	3,469
Debt Instrument, Unamortized Discount	(38)
Notes Payable	$ 5,260

Commitments (Details) - USD ($) $ in Millions	12 Months Ended
Commitments (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Unrecorded Unconditional Purchase Obligation [Line Items]
Commitments for purchase obligations	$ 7,600
Operating Leases, Rent Expense, Net [Abstract]
Rent expense	93	$ 63	$ 52
Operating Leases, Future Minimum Payments Due [Abstract]
2020	54
2021	64
2022	63
2023	59
2024	53
2025 and thereafter	459
Total operating lease commitments	$ 752

Contingencies (Details) ¥ in Millions, $ in Millions					12 Months Ended
Contingencies (Details) ¥ in Millions, $ in Millions	Oct. 03, 2019 lawsuit	Sep. 03, 2019 lawsuit	Jun. 07, 2019 lawsuit	Oct. 09, 2018 lawsuit	Aug. 29, 2019 USD ($) lawsuit patent	Aug. 29, 2019 CNY (¥) lawsuit patent
Pending Litigation \| Qimonda AG Inotera Share Purchase Proceedings
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation (in hundredths)					18.00%	18.00%
Loss contingency, judgment under appeal \| $					$ 1
Loss Contingency, Pending Claims, Number					1	1
Pending Litigation \| Micron vs United Microelectronics Corp and Fujian Jinhua Integrated Circuit Co
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					1	1
Pending Litigation \| Employee Class Action vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| MLC Intellectual Property, LLC vs Micron
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Elm 3DS Innovations, LLC vs Micron
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					13	13
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. vs Micron-Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					8	8
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Innovative Memory Solutions, Inc. vs Micron-Complaint 3
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 1
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 98
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 98
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| United Microelectronics Corporation vs Micron-Complaint 1
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 90
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| United Microelectronics Corporation vs Micron-Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 90
Loss Contingency, Pending Claims, Number					1	1
Patent Matters \| Pending Litigation \| Fuzhou Court Preliminary Injunction
Loss Contingencies [Line Items]
Percent of annualized revenue derived from impacted products					1.00%	1.00%
Patent Matters \| Dismissed Litigation \| Innovative Memory Solutions, Inc. vs Micron-Complaint 2
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Loss Contingency, Claims Dismissed, Number			1
Patent Matters \| Withdrawn Litigation \| United Microelectronics Corporation vs Micron-Complaint 3
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent					1	1
Damages sought on alleged patent infringement \| ¥						¥ 90
Loss Contingency, Claims Withdrawn, Number				1
Antitrust Matters \| Pending Litigation \| Initial direct DRAM Purchasers United States vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					1	1
Antitrust Matters \| Pending Litigation \| Subsequent direct DRAM Purchasers United States vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					4	4
Antitrust Matters \| Pending Litigation \| DRAM Purchasers Canada vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					6	6
Antitrust Matters \| Dismissed Litigation \| Initial indirect DRAM Purchasers United States vs Micron \| Subsequent Event
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number		1
Antitrust Matters \| Dismissed Litigation \| Subsequent indirect DRAM Purchasers United States vs Micron \| Subsequent Event
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number		2
Securities Matters \| Pending Litigation \| Shareholder Class Action Delaware Court vs Micron.
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number					1	1
Securities Matters \| Joined Litigation \| Original Shareholder Action New York vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Claims Joined, Number					1	1
Securities Matters \| Joined Litigation \| Subsequent Shareholder Claims New York vs Micron
Loss Contingencies [Line Items]
Loss Contingency, Claims Joined, Number					2	2
Securities Matters \| Dismissed Litigation \| Consolidated Shareholder Class Action New York Court vs Micron \| Subsequent Event
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number	1

Redeemable Noncontrolling Interest (Details) - Micron Semiconductor Asia Operations Pt. Ltd. - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018
Redeemable Noncontrolling Interest [Line Items]
Redeemable noncontrolling interest, shares authorized	100,000
Redeemable noncontrolling interest, shares Issued	100,000
Net proceeds from issuance of redeemable preferred stock		$ 97
Cumulative fixed dividend on redeemable noncontrolling interests	7.75%

Equity - Common Stock Repurchase Authorization (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Equity, Class of Treasury Stock [Line Items]
Payments for Repurchase of Common Stock	$ 2,729	$ 71	$ 36
Repurchases Authorized by the BOD
Equity, Class of Treasury Stock [Line Items]
Common Stock Repurchase, Authorized Amount	$ 10,000
Treasury Shares Repurchased (in shares)	67
Payments for Repurchase of Common Stock	$ 2,660

Equity - Common Stock Issuance (Details) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 30, 2018 USD ($) $ / shares shares
Statement of Stockholders' Equity [Abstract]
Common stock issued (in shares) \| shares	34
Price of common shares issued (in dollars per share) \| $ / shares	$ 41.00
Proceeds from common stock issuance \| $	$ 1,360

Equity - Treasury Stock (Details) - USD ($) shares in Millions, $ in Millions		12 Months Ended
	Dec. 06, 2016	Aug. 31, 2017
Treasury Stock
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		$ (1,029)
Retained Earnings
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		104
Inotera
Class of Stock [Line Items]
Proceeds from issuance of stock to Nanya	$ 986
Inotera \| Shares Issued to Nanya
Class of Stock [Line Items]
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares)	58
Proceeds from issuance of stock to Nanya	$ 986
Inotera \| Shares Issued to Nanya \| Treasury Stock
Class of Stock [Line Items]
Proceeds from issuance of stock to Nanya		925
Treasury shares included in sale of shares to Nanya (in shares)	54
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		(1,030)
Inotera \| Shares Issued to Nanya \| Retained Earnings
Class of Stock [Line Items]
Decrease in retained earnings (decrease in treasury stock) due to reissuance of treasury shares at price lower than purchase price		$ 104

Equity - Capped Calls (Details) - USD ($) $ / shares in Units, shares in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Option Indexed to Issuer's Equity [Line Items]
Value of shares received upon settlement of capped calls		$ 0	$ (125,000,000)
Treasury Stock
Option Indexed to Issuer's Equity [Line Items]
Value of shares received upon settlement of capped calls		$ 429,000,000	$ 67,000,000
Call Option \| Purchased options
Option Indexed to Issuer's Equity [Line Items]
2033F capped calls, underlying common shares (in shares)	27
2033F capped calls, initial strike price (in dollars per share)	$ 10.93
2033F capped calls, cap price (in dollars per share)	$ 14.51
Treasury shares from capped call settlement		9	4
Proceeds received upon settlement of capped calls			$ 125,000,000
Call Option \| Purchased options \| Treasury Stock
Option Indexed to Issuer's Equity [Line Items]
Value of shares received upon settlement of capped calls		$ 429,000,000	$ 67,000,000
Call Option \| Purchased options \| Minimum
Option Indexed to Issuer's Equity [Line Items]
2033F capped calls, potential value at expiration	$ 0
Call Option \| Purchased options \| Maximum
Option Indexed to Issuer's Equity [Line Items]
2033F capped calls, potential value at expiration	$ 98,000,000

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	$ 10
Other comprehensive income (loss)	(1)	$ (19)	$ 64
Accumulated other comprehensive income	9	10
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	10
Other comprehensive income	(13)
Amount reclassified out of accumulated other comprehensive income	4
Tax effects	3
Other comprehensive income (loss)	(6)
Accumulated other comprehensive income	4	10
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	2
Other comprehensive income	(3)
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	(3)
Accumulated other comprehensive income	(1)	2
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	0
Other comprehensive income	(1)
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	(1)
Accumulated other comprehensive income	(1)	0
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	(2)
Other comprehensive income	14
Amount reclassified out of accumulated other comprehensive income	(3)
Tax effects	(2)
Other comprehensive income (loss)	9
Accumulated other comprehensive income	7	(2)
Total Micron Shareholders' Equity
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income	10
Other comprehensive income	(3)
Amount reclassified out of accumulated other comprehensive income	1
Tax effects	1
Other comprehensive income (loss)	(1)	(19)	$ 64
Accumulated other comprehensive income	$ 9	$ 10

Equity - NCI and Consolidated VIE Disclosures (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

Nov. 28, 2019

Aug. 29, 2019

May 30, 2019

Feb. 28, 2019

Nov. 29, 2018

Aug. 30, 2018

May 31, 2018

Mar. 01, 2018

Nov. 30, 2017

Aug. 29, 2019

Aug. 30, 2018

Aug. 31, 2017

Noncontrolling Interest Balance

$ 889

$ 870

$ 889

$ 870

IMFT sales to Intel at prices approximating cost

4,870

$ 4,788

$ 5,835

$ 7,913

8,440

$ 7,797

$ 7,351

$ 6,803

23,406

30,391

$ 20,322

3,550

1,009

3,311

Repayments of debt

3,340

10,194

2,558

IMFT Member Debt | Convertible Debt

1,310

859

1,310

859

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

1,010

Repayments of debt

316

693

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

Intel | IM Flash Technologies, LLC

^[1]

696

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

IMFT sales to Intel at prices approximating cost

731

507

$ 493

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

Noncontrolling Interest Balance

$ 889

$ 853

$ 889

$ 853

Noncontrolling Interest Percentage (in hundredths)

49.00%

Ownership interest in IMFT (in hundredths)

51.00%

Joint Venture Agreement, Terms [Abstract]

Joint Venture Agreement, Terms, Partner Contribution Output Sharing Lag

8 months

Joint Venture Agreement, Terms, Intel Percentage of Lookback Supply from IMFT

50.00%

Joint Venture Agreement, Terms, Intel Supply Lookback Period

6 months

IM Flash Technologies, LLC | Forecast

Joint Venture Agreement, Terms [Abstract]

Forecasted purchase price of IMFT

$ 1,400

Other Consolidated Entities

Stockholders' Equity Attributable to Noncontrolling Interest [Abstract]

Noncontrolling Interest Balance

$ 0

$ 17

$ 0

$ 17

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Equity - Consolidated VIE assets and liabilities (Details) - USD ($)
$ in Millions

Aug. 29, 2019

Aug. 31, 2018

Aug. 30, 2018

Assets

Cash and equivalents

$ 7,152

$ 6,506

3,195

$ 5,592

5,478

Property, plant, and equipment

5,118

3,590

3,595

Other current assets

235

180

164

Total current assets

16,503

16,039

28,240

23,672

Other noncurrent assets

575

611

Total assets

48,887

43,376

Liabilities

Accounts payable and accrued expenses

4,626

4,374

Other current liabilities

1,310

859

454

517

521

Total current liabilities

6,390

5,754

Long-term debt

4,541

3,777

Other noncurrent liabilities

452

$ 355

354

Total liabilities

12,019

10,112

Assets

Cash and equivalents

^[1]

130

^[1]

128

126

Property, plant, and equipment

^[1]

124

114

Other current assets

^[1]

Total current assets

^[1]

391

339

^[1]

2,235

2,641

Other noncurrent assets

^[1]

Total assets

^[1]

2,664

3,025

Liabilities

Accounts payable and accrued expenses

^[1]

118

138

Other current liabilities

^[1]

696

^[1]

Total current liabilities

^[1]

851

167

Long-term debt

^[1]

1,064

Other noncurrent liabilities

^[1]

Total liabilities

^[1]

$ 909

$ 1,305

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Fair Value Measurements - Fair and Carrying Value of Debt (Details) - USD ($)
$ in Millions

12 Months Ended

Aug. 29, 2019

Aug. 30, 2018

Debt Instrument, Fair Value Disclosure [Abstract]

Carrying Value of Debt

^[1]

$ 5,851

$ 4,636

Unrealized losses on assets held for sale (level 3)

Fair Value | Notes and MMJ Creditor Payments

Debt Instrument, Fair Value Disclosure [Abstract]

Fair Value of Notes and MMJ Creditor Payments (level 2)

5,194

2,798

Fair Value | Convertible Notes

Debt Instrument, Fair Value Disclosure [Abstract]

Fair Value of Convertible notes (level 2)

852

3,124

Carrying Value | Notes and MMJ Creditor Payments

Debt Instrument, Fair Value Disclosure [Abstract]

Carrying Value of Debt

4,937

2,741

Carrying Value | Convertible Notes

Debt Instrument, Fair Value Disclosure [Abstract]

Carrying Value of Debt

$ 323

$ 1,049

[1]

Derivative Instruments - Notional Amounts and Fair Values (Details)
shares in Millions, $ in Millions

12 Months Ended

Aug. 29, 2019

USD ($)

Aug. 30, 2018

USD ($)

^[1]

$ 2

$ 14

Designated hedging instruments

^[2]

$ (188)

(190)

General maturity of currency forward contracts (in months)

12 months

Designated hedging instruments | Cash flow hedges | Currency forward

Notional Disclosures [Abstract]

Gross Notional Amount, Currency forwards

$ 146

538

^[1]

Not designated hedging instruments

^[2]

(13)

^[1]

General maturity of currency forward contracts (in months)

^[2]

$ (188)

(177)

3 months

Not designated hedging instruments | Currency forward

Notional Disclosures [Abstract]

Gross Notional Amount, Currency forwards

$ 1,871

1,919

^[1]

Not designated hedging instruments | Convertible notes settlement obligation

^[2]

$ (9)

$ (10)

Notional Disclosures [Abstract]

Gross Notional Amount, Convertible notes settlement obligation (in shares) | shares

^[1]

$ 0

^[2],[3]

$ (179)

$ (167)

[1]	Included in receivables – other.
[2]	Included in accounts payable and accrued expenses – other for forward contracts and in current debt for convertible notes settlement obligations.
[3]	Notional amounts of convertible notes settlement obligations as of August 29, 2019 and August 30, 2018 were 4 million and 3 million shares of our common stock, respectively.

Derivative Instruments - Gain (Loss) on Derivatives (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Designated hedging instruments \| Cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) recognized in other comprehensive income, effective portion	$ (3)	$ (17)	$ 15
Designated hedging instruments \| Fair value hedges
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Loss on remeasurement of hedged assets and liabilities	(25)
Gain on derivatives designated as hedged instruments	25
Amortization of amounts excluded from hedge effectiveness	(32)
Loss on fair value hedges recognized in earnings	(32)
Currency forward \| Not designated hedging instruments
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Net gains (losses) for derivative instruments without hedge accounting designation	(32)	(38)	$ (45)
Convertible notes settlement obligation \| Not designated hedging instruments
Gain (Loss) on Fair Value Hedges Recognized in Earnings [Abstract]
Net gains (losses) for derivative instruments without hedge accounting designation	$ (58)	$ (124)

Equity Plans - Share Based Awards (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	108
Restricted stock awards
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	15
Number of Shares - Granted (in shares)	9	4	8
Number of Shares - Restrictions lapsed (in shares)	(6)
Number of Shares - Canceled (in shares)	(2)
Number of Shares - Outstanding (in shares)	16	15
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 25.18
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	41.11	$ 42.48	$ 18.77
Weighted Average Grant Date Fair Value Per Share - Restrictions lapsed (in dollars per share)	24.22
Weighted Average Grant Date Fair Value Per Share - Canceled (in dollars per share)	24.79
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 34.72	$ 25.18
Restricted stock awards granted (in shares)	9	4	8
Weighted-average grant-date fair values per share (in dollars per share)	$ 41.11	$ 42.48	$ 18.77
Aggregate vesting-date fair value of shares vested	$ 248	$ 259	$ 115
Performance and Market-based Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award vesting period	3 years
Performance and Market-based Restricted Stock Awards \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award achievement potential, percentage	0.00%
Performance and Market-based Restricted Stock Awards \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Restricted award achievement potential, percentage	200.00%
Service-based Restricted Stock Awards
Restricted Stock Awards activity
Number of Shares - Outstanding (in shares)	14
Service-based Restricted Stock Awards \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	25.00%
Service-based Restricted Stock Awards \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	33.00%
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of shares outstanding (in shares)	18
Number of shares granted (in shares)	0	2	8
Number of shares exercised (in shares)	(5)
Number of shares canceled or expired (in shares)	(1)
Number of shares outstanding (in shares)	12	18
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 23.38
Weighted average exercise price per share for options granted (in dollars per share)	44.30
Weighted average exercise price per share for options exercised (in dollars per share)	17.50
Weighted average exercise price per share for options canceled or expired (in dollars per share)	22.60
Weighted average exercise price per share for options outstanding (in dollars per share)	$ 25.94	$ 23.38
Share-based Compensation Arrangement by Share-based Payment Award Options, Outstanding, Additional Disclosures [Abstract]
Weighted average remaining contractual term for options outstanding (in years)	4 years 3 months
Aggregated intrinsic value for options outstanding	$ 220
Options exercisable (in shares)	7
Weighted average exercise price per share for options exercisable (in dollars per share)	$ 25.37
Weighted average remaining contractual term for options exercisable (in years)	3 years 8 months
Aggregated intrinsic value for options exercisable	$ 143
Options unvested (in shares)	5
Weighted average exercise price per share for options unvested (in dollars per share)	$ 26.94
Weighted average remaining contractual term for options unvested (in years)	5 years 6 months
Aggregate intrinsic value for options unvested	$ 77
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]
Total intrinsic value for option exercised	$ 108	$ 446	$ 198
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Method Used	Black-Scholes
Stock options granted (in shares)	0	2	8
Weighted-average grant-date fair values per share (in dollars per share)	$ 19.50	$ 18.65	$ 8.68
Average expected life (in years)	5 years 5 months	5 years 6 months	5 years 6 months
Weighted-average expected volatility (in hundredths)	44.00%	44.00%	46.00%
Weighted-average risk-free interest rate (in thousandths)	2.90%	2.20%	1.80%
Expected dividend yield	0.00%	0.00%	0.00%
Employee stock option \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	25.00%
Employee stock option \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual vesting rights, percentage	33.00%
Employee stock option \| Awards Granted After February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years or months)	8 years
Employee stock option \| Awards Granted Prior to February 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
General number of years from grant date until stock options expire (in years or months)	6 years
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)	29
General number of years from grant date until stock options expire (in years or months)	6 months
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)	$ 11.60	$ 14.55
Weighted-average grant-date fair values per share (in dollars per share)	$ 11.60	$ 14.55
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Method Used	Black-Scholes
Average expected life (in years)	6 months	6 months
Weighted-average expected volatility (in hundredths)	45.00%	43.00%
Weighted-average risk-free interest rate (in thousandths)	2.20%	2.20%
Expected dividend yield	0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]
ESPP maximum payroll deduction percentage (in hundredths)	10.00%
ESPP percentage purchase price of common stock (in hundredths)	85.00%
ESPP shares purchased (in shares)	3
ESPP value of shares purchased	$ 95

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 243	$ 198	$ 215
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Tax benefit from compensation expense	66	158	97
Total unrecognized compensation costs related to non-vested awards expected to be recognized	$ 439
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	1 year 4 months
Restricted stock awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 178	140	144
Employee stock option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	33	55	71
Employee Stock Purchase Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	32	3	0
Equity plans
Share-based Payment Arrangement, Additional Disclosure [Abstract]
Stock compensation expense capitalized and remained in inventory	30	19
Cost of Goods Sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	102	83	88
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	73	61	75
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 68	$ 54	$ 52

Employee Benefit Plans - (Details) - USD ($) $ in Millions	12 Months Ended
Employee Benefit Plans - (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Employee Savings Plan for U.S. Employees
Maximum annual contributions per employee (in hundredths)	75.00%
Maximum employer matching contribution, percent of employees' eligible earnings (in hundredths)	5.00%
Defined contribution plan contribution expense	$ 67	$ 61	$ 52
Retirement Plans
Projected pension benefit obligation	206	190
Pension plan assets	$ 195	$ 171

Revenue and Contract Liabilities-Product Sales (Details) - USD ($)
$ in Millions

3 Months Ended

12 Months Ended

Aug. 29, 2019

May 30, 2019

Feb. 28, 2019

Nov. 29, 2018

Aug. 30, 2018

May 31, 2018

Mar. 01, 2018

Nov. 30, 2017

Aug. 29, 2019

Aug. 30, 2018

Aug. 31, 2017

$ 4,870

$ 4,788

$ 5,835

$ 7,913

$ 8,440

$ 7,797

$ 7,351

$ 6,803

$ 23,406

$ 30,391

$ 20,322

DRAM

15,247

21,232

12,963

NAND

^[1]

6,946

7,897

6,585

Other

$ 1,213

$ 1,262

$ 774

[1]	MCP revenue is reported within NAND.

Revenue and Contract Liabilities-Contract Liabilities and Customer Payables (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 31, 2018
Contract Liabilities
Contract liabilities	$ 130	$ 348
Revenue recognized from beginning balance	273
Consideration Payable to Customers
Estimated consideration payable to customers for pricing adjustments and returns	326
Contract liabilities from customer advances (product)
Contract Liabilities
Contract liabilities	61	235
Other contract liabilities
Contract Liabilities
Contract liabilities	$ 69	$ 113

Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
Research and Development (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Research and Development [Abstract]
Reduction in R and D expenses for reimbursements from partners	$ 60	$ 201	$ 213

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Restructuring Cost and Reserve [Line Items]
(Gain) loss on disposition of property, plant, and equipment	$ 43	$ (96)	$ (22)
Restructure and asset impairments	(29)	28	18
Other	35	11	5
Other operating (income) expense, net	49	$ (57)	1
Restructuring and Related Activities [Abstract]
Gain on asset sales and dispositions	$ 128		$ 15
Tera Probe
Restructuring and Related Activities [Abstract]
Ownership interest in Tera Probe disposed of during 2017			40.00%

Other Non-Operating Income (Expense), Net (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Other Nonoperating Income (Expense) [Abstract]
Loss on debt prepayments, repurchases, and conversions	$ (396)	$ (385)	$ (100)
Loss from changes in currency exchange rates	(9)	(75)	(74)
Gain on remeasurement of previously-held equity interest in Inotera	0	0	71
Other	0	(5)	(9)
Other non-operating income (expense), net	$ (405)	$ (465)	$ (112)

Income Taxes - Income (loss) before Taxes and Other Items (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
U.S.	$ (67)	$ 141	$ (56)
Foreign	7,115	14,166	5,252
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees	7,048	14,307	5,196
Current [Abstract]
U.S. federal	(36)	(54)	0
State	(2)	1	(1)
Foreign	(319)	(374)	(152)
Total income tax (provision) benefit - current	(357)	(427)	(153)
Deferred [Abstract]
U.S. federal	(146)	232	0
State	91	101	0
Foreign	(281)	(74)	39
Total income tax (provision) benefit - deferred	(336)	259	39
Income tax (provision) benefit	$ (693)	$ (168)	$ (114)

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. federal income tax (provision) benefit at statutory rate	$ (1,480)	$ (3,677)	$ (1,819)
Foreign tax rate differential	993	2,606	1,600
U.S. tax on foreign operations	(327)	(20)	(37)
Repatriation Tax related to the Tax Act	(10)	(1,049)	0
Remeasurement of deferred tax assets and liabilities related to the Tax Act	0	(179)	0
Change in valuation allowance	(40)	2,079	64
State taxes, net of federal benefit	102	(84)	0
Research and development tax credits	118	90	66
Other	(49)	66	12
Income tax (provision) benefit	$ (693)	$ (168)	$ (114)
Effective Income Tax Rate Reconciliation, Percent [Abstract]
U.S. federal statutory rate (percent)	21.00%	25.70%	35.00%
Foreign tax rate differential (percent)	(14.10%)	(18.20%)	(30.80%)
U.S. tax on foreign operations (percent)	4.60%	0.10%	0.70%
Repatriation Tax related to the Tax Act (percent)	0.001	0.073	0.000
Remeasurement of deferred tax assets and liabilities related to the Tax Act (percent)	0.00%	1.30%	0.00%
Change in valuation allowance (percent)	0.60%	(14.50%)	(1.20%)
State taxes, net of federal benefit (percent)	(1.40%)	0.60%	0.00%
Research and development tax credits (percent)	(1.70%)	(0.60%)	(1.30%)
Other (percent)	0.70%	(0.50%)	(0.20%)
Effective tax rate (percent)	9.80%	1.20%	2.20%
Measurement period benefit, net of uncertain tax positions	$ 47
Provisional benefit for release of valuation allowance on net deferred tax assets of US operations		$ 1,340
Provisional Repatriation Tax expense, net of adjustments related to uncertain tax positions		$ 1,030

Income Taxes Income Taxes - Tax Holiday (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Income Tax Disclosure [Abstract]
Tax benefit from incentive arrangements	$ 756	$ 1,960	$ 742
Tax benefit per diluted share from incentive arrangements	$ 0.66	$ 1.59	$ 0.64

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Aug. 29, 2019	Aug. 31, 2018	Aug. 30, 2018
Income Tax Disclosure [Abstract]
Deferred tax liability, undistributed foreign earnings	$ 10
Undistributed earnings of foreign subsidiaries deemed indefinitely reinvested	2,840
Deferred Tax Assets Abstract]
Net operating loss and tax credit carryforwards	1,045		$ 1,417
Accrued salaries, wages, and benefits	122		163
Property, plant, and equipment	80		0
Other	110		115
Gross deferred tax assets	1,357		1,695
Less valuation allowance	(277)		(228)
Deferred tax assets, net of valuation allowance	1,080		1,467
Deferred Tax Liabilities [Abstract]
Product and process technology	(138)		(62)
Property, plant, and equipment	0		(173)
Other	(109)		(213)
Deferred tax liabilities	(247)		(448)
Net deferred tax assets	833		1,019
Reported as [Abstract]
Deferred tax assets	837	$ 986	1,022
Deferred tax liabilities (included in other noncurrent liabilities)	$ (4)		$ (3)

Income Taxes - Tax Credit Carryforwards (Details) $ in Millions	Aug. 29, 2019 USD ($)
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 658
2020 - 2024
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	55
2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	58
2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	116
2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	354
Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	75
U.S. Federal
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	353
U.S. Federal \| 2020 - 2024
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal \| 2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal \| 2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	3
U.S. Federal \| 2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	350
U.S. Federal \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
State
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	305
State \| 2020 - 2024
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	55
State \| 2025 - 2029
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	58
State \| 2030 - 2034
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	113
State \| 2035 - 2039
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	4
State \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 75

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning unrecognized tax benefits	$ 261	$ 327	$ 304
Increases related to tax positions from prior years	124	0	0
Increases related to tax positions taken in current year	44	68	15
Decreases related to tax positions from prior years	(46)	(126)	0
Settlements with tax authorities	0	(8)	(47)
Increases due to the Inotera Acquisition	0	0	54
Other	0	0	1
Ending unrecognized tax benefits	$ 383	$ 261	$ 327

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended								12 Months Ended
	Aug. 29, 2019	May 30, 2019	Feb. 28, 2019	Nov. 29, 2018	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Earnings Per Share Reconciliation [Abstract]
Net income attributable to Micron - Basic	$ 561	$ 840	$ 1,619	$ 3,293	$ 4,325	$ 3,823	$ 3,309	$ 2,678	$ 6,313	$ 14,135	$ 5,089
Assumed conversion of debt									(12)	0	0
Net income attributable to Micron - Diluted									$ 6,301	$ 14,135	$ 5,089
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]
Weighted-average common shares outstanding - Basic (in shares)									1,114	1,152	1,089
Dilutive effect of equity plans and convertible notes (in shares)									29	77	65
Weighted-average common shares outstanding - Diluted (in shares)									1,143	1,229	1,154
Earnings per share
Basic (in dollars per share)	$ 0.51	$ 0.76	$ 1.45	$ 2.91	$ 3.73	$ 3.30	$ 2.86	$ 2.36	$ 5.67	$ 12.27	$ 4.67
Diluted (in dollars per share)	$ 0.49	$ 0.74	$ 1.42	$ 2.81	$ 3.56	$ 3.10	$ 2.67	$ 2.19	$ 5.51	$ 11.51	$ 4.41

Earnings Per Share - Antidilutive Securities (Details) - shares shares in Millions	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Equity plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	8	3	21
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	0	0	26

Segment Information (Details) $ in Millions	3 Months Ended								12 Months Ended
Segment Information (Details) $ in Millions	Aug. 29, 2019 USD ($)	May 30, 2019 USD ($)	Feb. 28, 2019 USD ($)	Nov. 29, 2018 USD ($)	Aug. 30, 2018 USD ($)	May 31, 2018 USD ($)	Mar. 01, 2018 USD ($)	Nov. 30, 2017 USD ($)	Aug. 29, 2019 USD ($) segment	Aug. 30, 2018 USD ($)	Aug. 31, 2017 USD ($)
Reportable Segments
Number of reportable segments \| segment									4
Segment Reporting Information, Additional Information [Abstract]
Goodwill	$ 1,228				$ 1,228				$ 1,228	$ 1,228
Net sales
Revenue	4,870	$ 4,788	$ 5,835	$ 7,913	8,440	$ 7,797	$ 7,351	$ 6,803	23,406	30,391	$ 20,322
Operating income (loss)
Stock-based compensation									(243)	(198)	(215)
Restructure and asset impairments									29	(28)	(18)
Other									(49)	57	(1)
Operating income (loss)	650	$ 1,010	$ 1,957	$ 3,759	4,377	$ 3,953	$ 3,567	$ 3,097	7,376	14,994	5,868
Depreciation and amortization
Depreciation and amortization expense by segment									5,424	4,759	3,861
CNBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	832				832				832	832
Net sales
Revenue									9,968	15,252	8,624
MBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	198				198				198	198
Net sales
Revenue									6,403	6,579	4,424
SBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	101				101				101	101
Net sales
Revenue									3,826	5,022	4,514
EBU
Segment Reporting Information, Additional Information [Abstract]
Goodwill	$ 97				$ 97				97	97
Net sales
Revenue									3,137	3,479	2,695
All Other
Net sales
Revenue									72	59	65
Operating Segments
Operating income (loss)
Operating income (loss)									7,801	15,243	6,232
Operating Segments \| CNBU
Operating income (loss)
Operating income (loss)									4,645	9,773	3,755
Depreciation and amortization
Depreciation and amortization expense by segment									1,833	1,755	1,344
Operating Segments \| MBU
Operating income (loss)
Operating income (loss)									2,606	3,033	927
Depreciation and amortization
Depreciation and amortization expense by segment									1,235	1,077	926
Operating Segments \| SBU
Operating income (loss)
Operating income (loss)									(386)	964	552
Depreciation and amortization
Depreciation and amortization expense by segment									1,555	1,295	1,083
Operating Segments \| EBU
Operating income (loss)
Operating income (loss)									923	1,473	975
Depreciation and amortization
Depreciation and amortization expense by segment									748	603	484
Operating Segments \| All Other
Operating income (loss)
Operating income (loss)									13	0	23
Depreciation and amortization
Depreciation and amortization expense by segment									27	18	13
Unallocated
Operating income (loss)
Stock-based compensation									(243)	(198)	(215)
Employee severance									(116)	0	0
Start-up and preproduction costs									(58)	0	0
Restructure and asset impairments									32	(28)	(18)
Flow-through of Inotera inventory step up									0	0	(107)
Other									(40)	(23)	(24)
Operating income (loss)									(425)	(249)	(364)
Depreciation and amortization
Depreciation and amortization expense by segment									$ 26	$ 11	$ 11

Certain Concentrations (Details) - Revenue from Contract with Customer	12 Months Ended
	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Product Concentration Risk \| Mobile
Concentration Risk [Line Items]
Concentration Risk, Percentage	25.00%	20.00%	20.00%
Product Concentration Risk \| Client and graphics
Concentration Risk [Line Items]
Concentration Risk, Percentage	20.00%	25.00%	20.00%
Product Concentration Risk \| Enterprise and cloud server
Concentration Risk [Line Items]
Concentration Risk, Percentage	20.00%	25.00%	15.00%
Product Concentration Risk \| SSDs and other storage
Concentration Risk [Line Items]
Concentration Risk, Percentage	15.00%	15.00%	20.00%
Product Concentration Risk \| Automotive, industrial, and consumer
Concentration Risk [Line Items]
Concentration Risk, Percentage	15.00%	10.00%	15.00%
Customer Concentration Risk \| Huawei
Concentration Risk [Line Items]
Concentration Risk, Percentage	12.00%
Customer Concentration Risk \| Kingston
Concentration Risk [Line Items]
Concentration Risk, Percentage	11.00%	10.00%	10.00%

Geographic Information (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
Geographic Information (Details) - USD ($) $ in Millions	Aug. 29, 2019	May 30, 2019	Feb. 28, 2019	Nov. 29, 2018	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Geographic Areas, Revenues from External Customers [Abstract]
Revenue	$ 4,870	$ 4,788	$ 5,835	$ 7,913	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 23,406	$ 30,391	$ 20,322
Geographic Revenue Allocation Basis									geographic location of our customer's headquarters
Geographic Risk Allocation Basis									ship-to locations specified by our customers
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	28,240				23,672				$ 28,240	23,672
United States
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									12,451	17,116	$ 11,359
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	5,048				5,113				$ 5,048	$ 5,113
United States \| Revenue from Contract with Customer \| Geographic Concentration Risk
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Concentration Risk by Ship-to Location, Percentage									11.00%	12.00%	14.00%
Mainland China (excluding Hong Kong)
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									$ 3,595	$ 3,607	$ 1,539
China
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	370				398				$ 370	$ 398
China \| Revenue from Contract with Customer \| Geographic Concentration Risk
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Concentration Risk by Ship-to Location, Percentage									53.00%	57.00%	51.00%
Taiwan
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									$ 2,703	$ 3,918	$ 2,892
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	9,397				7,640				$ 9,397	$ 7,640
Taiwan \| Revenue from Contract with Customer \| Geographic Concentration Risk
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Concentration Risk by Ship-to Location, Percentage									13.00%	9.00%	13.00%
Hong Kong
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									$ 1,614	$ 1,761	$ 1,429
Other Asia Pacific
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									1,032	1,458	1,078
Japan
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									958	1,265	1,042
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	5,202				3,451				5,202	3,451
Singapore
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	7,986				6,933				7,986	6,933
Other
Geographic Areas, Revenues from External Customers [Abstract]
Revenue									1,053	1,266	$ 983
Geographic Areas, Long-Lived Assets [Abstract]
Property, plant, and equipment, net	$ 237				$ 137				$ 237	$ 137

Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Aug. 29, 2019	May 30, 2019	Feb. 28, 2019	Nov. 29, 2018	Aug. 30, 2018	May 31, 2018	Mar. 01, 2018	Nov. 30, 2017	Aug. 29, 2019	Aug. 30, 2018	Aug. 31, 2017
Quarterly Financial Information Disclosure [Abstract]
Revenue	$ 4,870	$ 4,788	$ 5,835	$ 7,913	$ 8,440	$ 7,797	$ 7,351	$ 6,803	$ 23,406	$ 30,391	$ 20,322
Gross margin	1,395	1,828	2,864	4,615	5,151	4,723	4,270	3,747	10,702	17,891	8,436
Operating income	650	1,010	1,957	3,759	4,377	3,953	3,567	3,097	7,376	14,994	5,868
Net income	586	851	1,625	3,296	4,326	3,823	3,311	2,678	6,358	14,138	5,090
Net income attributable to Micron	$ 561	$ 840	$ 1,619	$ 3,293	$ 4,325	$ 3,823	$ 3,309	$ 2,678	$ 6,313	$ 14,135	$ 5,089
Earnings per share
Basic (in dollars per share)	$ 0.51	$ 0.76	$ 1.45	$ 2.91	$ 3.73	$ 3.30	$ 2.86	$ 2.36	$ 5.67	$ 12.27	$ 4.67
Diluted (in dollars per share)	$ 0.49	$ 0.74	$ 1.42	$ 2.81	$ 3.56	$ 3.10	$ 2.67	$ 2.19	$ 5.51	$ 11.51	$ 4.41

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686